DYRK1A
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | S493 | Sugiyama | SHTN1 KIAA1598 | sEtELERILRRRKVtAEADsssPtGILAtsEsKsMPVLGsV |
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00151 | S90 | Sugiyama | PDLIM1 CLIM1 CLP36 | IKGCTDNLtLtVARsEHKVWsPLVtEEGKRHPYKMNLASEP |
| O00178 | S12 | Sugiyama | GTPBP1 | _________MATERsRsAMDsPVPAsMFAPEPssPGAARAA |
| O00178 | S6 | Sugiyama | GTPBP1 | _______________MATERsRsAMDsPVPAsMFAPEPssP |
| O00178 | S8 | Sugiyama | GTPBP1 | _____________MATERsRsAMDsPVPAsMFAPEPssPGA |
| O00193 | S17 | Sugiyama | SMAP C11orf58 | ____MsAARESHPHGVKRsAsPDDDLGssNWEAADLGNEER |
| O00193 | S25 | Sugiyama | SMAP C11orf58 | RESHPHGVKRsAsPDDDLGssNWEAADLGNEERKQKFLRLM |
| O00264 | S54 | Sugiyama | PGRMC1 HPR6.6 PGRMC | LLGLCIFLLYKIVRGDQPAAsGDsDDDEPPPLPRLKRRDFt |
| O00264 | S57 | Sugiyama | PGRMC1 HPR6.6 PGRMC | LCIFLLYKIVRGDQPAAsGDsDDDEPPPLPRLKRRDFtPAE |
| O00429 | S126 | Sugiyama | DNM1L DLP1 DRP1 | EIRQEIENETERISGNNKGVsPEPIHLKIFSPNVVNLTLVD |
| O14545 | S327 | Sugiyama | TRAFD1 FLN29 | DHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQNFLQQAAS |
| O14639 | S431 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | TSGYDDKQERQsLGEsPRtLsPtPsAEGyQDVRDRMIHRst |
| O14639 | T433 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | GYDDKQERQsLGEsPRtLsPtPsAEGyQDVRDRMIHRstsQ |
| O15047 | S470 | Sugiyama | SETD1A KIAA0339 KMT2F SET1 SET1A | sPEREEVRtsPRPAsPARsGsPAPEttNESVPFAQHSSLDS |
| O15061 | S1044 | Sugiyama | SYNM DMN KIAA0353 SYN | ASEMEKAVESVVREsLsRQRsPAPGsPDEEGGAEAPAAGIR |
| O43524 | S330 | SIGNOR | FOXO3 FKHRL1 FOXO3A | RsRTNsNAsTVsGRLSPIMAsTELDEVQDDDAPLsPMLYSS |
| O43597 | T75 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SPRY2 | ytEGPTVVPRPGLKPAPRPStQHKHERLHGLPEHRQPPRLQ |
| O60664 | S175 | Sugiyama | PLIN3 M6PRBP1 TIP47 | RGAVQSGVDKTKsVVtGGVQsVMGsRLGQMVLsGVDtVLGK |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75179 | S2401 | Sugiyama | ANKRD17 GTAR KIAA0697 | CSSASNDSSAQSVSSGVRAPsPAPssVPLGSEKPSNVSQDR |
| O75533 | T273 | EPSD|PSP | SF3B1 SAP155 | IWDPtPsHtPAGAAtPGRGDtPGHAtPGHGGAtssARKNRW |
| O75533 | T434 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | SF3B1 SAP155 | VLPPPAGYVPIRtPARKLtAtPtPLGGMtGFHMQTEDRTMK |
| O76039 | S308 | EPSD|PSP | CDKL5 STK9 | TEQCLNHPTFQTQRLLDRsPsRSAKRKPYHVESSTLSNRNQ |
| O94826 | S91 | Sugiyama | TOMM70 KIAA0719 TOM70 TOMM70A | RGDASGLKRNSERKtPEGRAsPAPGsGHPEGPGAHLDMNsL |
| O94826 | S96 | Sugiyama | TOMM70 KIAA0719 TOM70 TOMM70A | GLKRNSERKtPEGRAsPAPGsGHPEGPGAHLDMNsLDRAQA |
| O94842 | S178 | Sugiyama | TOX4 C14orf92 KIAA0737 | GGGTILPPAQSPEDRLsttPsPtssLHEDGVEDFRRQLPSQ |
| O94842 | T176 | Sugiyama | TOX4 C14orf92 KIAA0737 | SLGGGTILPPAQSPEDRLsttPsPtssLHEDGVEDFRRQLP |
| O94979 | S799 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | IMQLRDRLCRAQGEPVAGHEsPKIPyEKQQLPKGRPGPVAG |
| O95359 | S2512 | Sugiyama | TACC2 | KQDYPQPSDLSTFVNETKFssPtEELDyRNsYEIEyMEKIG |
| O95644 | S261 | EPSD|PSP | NFATC1 NFAT2 NFATC | sPRAsVTEESWLGARssRPAsPCNKRKYsLNGRQPPysPHH |
| O95644 | S278 | EPSD|PSP | NFATC1 NFAT2 NFATC | RPAsPCNKRKYsLNGRQPPysPHHsPtPSPHGsPRVsVTDD |
| O95644 | S403 | EPSD|PSP | NFATC1 NFAT2 NFATC | CDQYLAVPQHPYQWAKPKPLsPTSYMsPTLPALDWQLPSHS |
| O95644 | S409 | EPSD|PSP | NFATC1 NFAT2 NFATC | VPQHPYQWAKPKPLsPTSYMsPTLPALDWQLPSHSGPYELR |
| O95817 | S173 | Sugiyama | BAG3 BIS | QVAAAAAAQPPAsHGPERsQsPAAsDCsssSsSAsLPssGR |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04637 | S15 | SIGNOR|EPSD|PSP | TP53 P53 | ______MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPL |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04920 | S172 | Sugiyama | SLC4A2 AE2 EPB3L1 HKB3 MPB3L | VQFFLQEDDSADRKAERtsPssPAPLPHQEAtPRASKGAQA |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07814 | T737 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRV |
| P07942 | T1141 | Sugiyama | LAMB1 | FWGDPDVECRACDCDPRGIEtPQCDQSTGQCVCVEGVEGPR |
| P08151 | S408 | EPSD|PSP | GLI1 GLI | GPDAHVtKRHRGDGPLPRAPsISTVEPKREREGGPIREESR |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P10636 | S519 | SIGNOR | MAPT MAPTL MTBT1 TAU | PPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPPTRE |
| P10636 | S721 | SIGNOR | MAPT MAPTL MTBT1 TAU | AKTDHGAEIVyKsPVVsGDtsPRHLsNVsstGsIDMVDsPQ |
| P10636 | T529 | SIGNOR | MAPT MAPTL MTBT1 TAU | GDRsGyssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtP |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P12270 | S652 | Sugiyama | TPR | sLDDVsLAstPKRPstsQtVstPAPVPVIESTEAIEAKAAL |
| P12270 | T650 | Sugiyama | TPR | AssLDDVsLAstPKRPstsQtVstPAPVPVIESTEAIEAKA |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S595 | Sugiyama | EEF2 EF2 | PVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGLAE |
| P13804 | S192 | Sugiyama | ETFA | sFDAAATsGGsASsEKAsStsPVEIsEWLDQKLTKSDRPEL |
| P13807 | S641 | SIGNOR | GYS1 GYS | FTYEPNEADAAQGyRyPRPAsVPPsPsLsRHssPHQsEDEE |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14866 | S101 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | GAAGGGGGGENyDDPHKtPAsPVVHIRGLIDGVVEADLVEA |
| P15559 | S82 | Sugiyama | NQO1 DIA4 NMOR1 | DPANFQYPAESVLAYKEGHLsPDIVAEQKKLEAADLVIFQF |
| P17066 | T40 | Sugiyama | HSPA6 HSP70B' | VGVFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQ |
| P17812 | S573 | Sugiyama | CTPS1 CTPS | HYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD__ |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17980 | S376 | Sugiyama | PSMC3 TBP1 | MPNEEARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQC |
| P18827 | S233 | Sugiyama | SDC1 SDC | FETSGENTAVVAVEPDRRNQsPVDQGAtGAsQGLLDRKEVL |
| P21333 | S1084 | Sugiyama | FLNA FLN FLN1 | PTKPSKVKAFGPGLQGGsAGsPARFtIDTKGAGTGGLGLTV |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P23396 | T221 | Sugiyama | RPS3 OK/SW-cl.26 | KKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVP |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23588 | T205 | Sugiyama | EIF4B | GRDRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYR |
| P24385 | T286 | SIGNOR|EPSD|PSP | CCND1 BCL1 PRAD1 | MDPKAAEEEEEEEEEVDLACtPtDVRDVDI___________ |
| P24928 | S1616 | EPSD|PSP | POLR2A POLR2 | TSPAYEPRSPGGYTPQSPSysPtsPsYsPTsPSYSPTSPNY |
| P24928 | S1619 | EPSD|PSP | POLR2A POLR2 | AYEPRSPGGYTPQSPSysPtsPsYsPTsPSYSPTSPNYSPT |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25786 | S14 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQGSA |
| P25789 | S13 | Sugiyama | PSMA4 HC9 PSC9 | ________MSRRyDsRttIFsPEGRLYQVEYAMEAIGHAGT |
| P25789 | T9 | Sugiyama | PSMA4 HC9 PSC9 | ____________MSRRyDsRttIFsPEGRLYQVEYAMEAIG |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27824 | S362 | Sugiyama | CANX | WDEDMDGEWEAPQIANPRCEsAPGCGVWQRPVIDNPNyKGK |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | T287 | Sugiyama | TKT | AEQIIQEIysQIQsKKKILAtPPQEDAPsVDIANIRMPsLP |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P30041 | T44 | Sugiyama | PRDX6 AOP2 KIAA0106 | RFHDFLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKR |
| P30086 | T51 | Sugiyama | PEBP1 PBP PEBP | GAAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDP |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P31943 | S104 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P35251 | S1088 | Sugiyama | RFC1 RFC140 | KEAHLtPYsLQAIKASRHstsPSLDsEyNEELNEDDsQsDE |
| P35269 | T389 | Sugiyama | GTF2F1 RAP74 | PPKRERKPsGGSSRGNsRPGtPsAEGGstsstLRAAASKLE |
| P35613 | S278 | Sugiyama | BSG UNQ6505/PRO21383 | ITDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQ |
| P35998 | T193 | Sugiyama | PSMC2 MSS1 | TYSDVGGCKEQIEKLREVVEtPLLHPERFVNLGIEPPKGVL |
| P36578 | S295 | Sugiyama | RPL4 RPL1 | sNyNLPMHKMINtDLsRILKsPEIQRALRAPRKKIHRRVLK |
| P37275 | S704 | Sugiyama | ZEB1 AREB6 TCF8 | tNsPVLPVGsttNGsRsstPsPsPLNLSSSRNTQGYLYTAE |
| P37275 | T702 | Sugiyama | ZEB1 AREB6 TCF8 | KMtNsPVLPVGsttNGsRsstPsPsPLNLSSSRNTQGYLYT |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P37840 | S87 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SNCA NACP PARK1 | GGAVVTGVTAVAQKTVEGAGsIAAATGFVKKDQLGKNEEGA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P41091 | T109 | Sugiyama | EIF2S3 EIF2G | YKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLVRH |
| P42166 | S79 | Sugiyama | TMPO LAP2 | sKGPPDFssDEEREPtPVLGsGAAAAGRSRAAVGRKATKKT |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42166 | T74 | Sugiyama | TMPO LAP2 | PAGTNsKGPPDFssDEEREPtPVLGsGAAAAGRSRAAVGRK |
| P42167 | S79 | Sugiyama | TMPO LAP2 | SKGPPDFssDEEREPtPVLGsGAAAAGRSRAAVGRKATKKT |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P42167 | T74 | Sugiyama | TMPO LAP2 | PAGTNSKGPPDFssDEEREPtPVLGsGAAAAGRSRAAVGRK |
| P42677 | S11 | Sugiyama | RPS27 MPS1 | __________MPLAKDLLHPsPEEEKRKHKKKRLVQsPNsy |
| P46013 | S1131 | Sugiyama | MKI67 | tPGPsEEsMtDEKTTKIACKsPPPEsVDtPtstKQWPKRSL |
| P46013 | S1983 | Sugiyama | MKI67 | tPGHtEEsMtDDKITEVsCKsPQPDPVKtPtsSKQRLKISL |
| P46013 | S2105 | Sugiyama | MKI67 | tPDHTEESttDDKTTKIACKsPPPEsMDtPTstRRRPKtPL |
| P48741 | T40 | Sugiyama | HSPA7 HSP70B | VGVFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQ |
| P49023 | S303 | Sugiyama | PXN | QRADGERCWAAGWPRDGGRssPGGQDEGGFMAQGKtGsssP |
| P49418 | S262 | SIGNOR | AMPH AMPH1 | AFTIQGAPSDSGPLRIAKtPsPPEEPsPLPsPtAsPNHTLA |
| P49418 | S272 | SIGNOR | AMPH AMPH1 | SGPLRIAKtPsPPEEPsPLPsPtAsPNHTLAPAsPAPARPR |
| P49418 | S276 | SIGNOR | AMPH AMPH1 | RIAKtPsPPEEPsPLPsPtAsPNHTLAPAsPAPARPRsPsQ |
| P49418 | S285 | SIGNOR | AMPH AMPH1 | EEPsPLPsPtAsPNHTLAPAsPAPARPRsPsQTRKGPPVPP |
| P49418 | S293 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | AMPH AMPH1 | PtAsPNHTLAPAsPAPARPRsPsQTRKGPPVPPLPKVtPtK |
| P49418 | S295 | GPS6|SIGNOR|EPSD|PSP | AMPH AMPH1 | AsPNHTLAPAsPAPARPRsPsQTRKGPPVPPLPKVtPtKEL |
| P49418 | T310 | GPS6|SIGNOR|EPSD|PSP | AMPH AMPH1 | RPRsPsQTRKGPPVPPLPKVtPtKELQQENIISFFEDNFVP |
| P49418 | T312 | EPSD|PSP | AMPH AMPH1 | RsPsQTRKGPPVPPLPKVtPtKELQQENIISFFEDNFVPEI |
| P51812 | S715 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | APHLVKGAMAAtysALNRNQsPVLEPVGRsTLAQRRGIKKI |
| P51991 | S358 | Sugiyama | HNRNPA3 HNRPA3 | QQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF |
| P53805 | S167 | SIGNOR|EPSD|PSP | RCAN1 ADAPT78 CSP1 DSC1 DSCR1 | GSSHLAPPNPDKQFLIsPPAsPPVGWKQVEDAtPVINYDLL |
| P53805 | T247 | EPSD|PSP | RCAN1 ADAPT78 CSP1 DSC1 DSCR1 | EMERMRRPKPKIIQTRRPEYtPIHLS_______________ |
| P54259 | S101 | Sugiyama | ATN1 D12S755E DRPLA | sEETNAPKKTKtEQELPRPQsPsDLDsLDGRsLNDDGSsDP |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P55211 | T125 | GPS6 | CASP9 MCH6 | NLtPVVLRPEIRKPEVLRPEtPRPVDIGSGGFGDVGALEsL |
| P55795 | S104 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T214 | Sugiyama | TPI1 TPI | KsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGG |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P61916 | S40 | Sugiyama | NPC2 HE1 | EPVQFKDCGsVDGVIKEVNVsPCPtQPCQLSKGQSYSVNVT |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62263 | T107 | Sugiyama | RPS14 PRO2640 | ELGITALHIKLRATGGNRtKtPGPGAQsALRALARSGMKIG |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62750 | S43 | Sugiyama | RPL23A | KAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPRK |
| P62750 | T42 | Sugiyama | RPL23A | LKAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPR |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| Q00059 | S160 | Sugiyama | TFAM TCF6 TCF6L2 | RKAMTKKKELTLLGKPKRPRsAYNVyVAERFQEAKGDsPQE |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q01082 | S2197 | Sugiyama | SPTBN1 SPTB2 | KTALPAQsAAtLPARtQEtPsAQMEGFLNRKHEWEAHNKKA |
| Q01082 | T2192 | Sugiyama | SPTBN1 SPTB2 | sDRKAKTALPAQsAAtLPARtQEtPsAQMEGFLNRKHEWEA |
| Q02790 | S15 | Sugiyama | FKBP4 FKBP52 | ______MTAEEMKAtEsGAQsAPLPMEGVDIsPKQDEGVLK |
| Q04637 | T207 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | QGGKDITEEIMsGARtAstPtPPQtGGGLEPQANGEtPQVA |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05193 | S795 | SIGNOR | DNM1 DNM | PTSsPtPQRRAPAVPPARPGsRGPAPGPPPAGSALGGAPPV |
| Q05193 | S857 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | DNM1 DNM | NRAPPGVPSRSGQAsPSRPEsPRPPFDL_____________ |
| Q07955 | S238 | SIGNOR | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | RsNsRsRsYsPRRsRGsPRYsPRHSRSRSRT__________ |
| Q07960 | S51 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | KNWPsDEMPDFPKsDDsKsssPELVtHLKWDDPyyDIARHQ |
| Q08AD1 | S1321 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | sVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWENAsttssV |
| Q08AD1 | S673 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | DASKFLQDyDIRTGNTREALsPCPsTVsTKSQPGSSAssss |
| Q08J23 | S743 | Sugiyama | NSUN2 SAKI TRM4 | AstGQPDNDVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGV |
| Q08J23 | S751 | Sugiyama | NSUN2 SAKI TRM4 | DVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGVHPPR____ |
| Q09666 | S93 | Sugiyama | AHNAK PM227 | LLNTMGHHTVGLKLHRKGDRsPEPGQtWtREVFssCssEVV |
| Q12778 | S322 | EPSD | FOXO1 FKHR FOXO1A | HsNDDFDNWSTFRPRtssNAstIsGRLsPIMtEQDDLGEGD |
| Q12778 | S329 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | FOXO1 FKHR FOXO1A | NWSTFRPRtssNAstIsGRLsPIMtEQDDLGEGDVHSMVYP |
| Q12913 | S303 | Sugiyama | PTPRJ DEP1 | DPLGTEGGLDASNTERSRAGsPTAPVHDESLVGPVDPSSGQ |
| Q13114 | S75 | PSP | TRAF3 CAP-1 CRAF1 TRAFAMN | KCHLVLCSPKQTECGHRFCEsCMAALLSSSSPKCTACQESI |
| Q13114 | S9 | PSP | TRAF3 CAP-1 CRAF1 TRAFAMN | ____________MESSKKMDsPGALQTNPPLKLHTDRSAGt |
| Q13114 | T29 | PSP | TRAF3 CAP-1 CRAF1 TRAFAMN | sPGALQTNPPLKLHTDRSAGtPVFVPEQGGYKEKFVKTVED |
| Q13158 | S194 | Sugiyama | FADD MORT1 GIG3 | ADLVQEVQQARDLQNRsGAMsPMsWNsDAsTSEAS______ |
| Q13247 | S301 | Sugiyama | SRSF6 SFRS6 SRP55 | PKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKR |
| Q13247 | S303 | Sugiyama | SRSF6 SFRS6 SRP55 | ENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKRAT |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13586 | S620 | Sugiyama | STIM1 GOK | sPsAPPGGsPHLDssRsHsPssPDPDtPsPVGDSRALQASR |
| Q13627 | S258 | GPS6 | DYRK1A DYRK MNB MNBH | FEMLSYNLYDLLRNTNFRGVsLNLTRKFAQQMCTALLFLAT |
| Q13627 | S519 | iPTMNet|EPSD | DYRK1A DYRK MNB MNBH | MEQsQssGttSSTSSSSGGSsGTSNSGRARsDPTHQHRHsG |
| Q13627 | S529 | GPS6|SIGNOR|EPSD|PSP | DYRK1A DYRK MNB MNBH | SSTSSSSGGSsGTSNSGRARsDPTHQHRHsGGHFtAAVQAM |
| Q13627 | S748 | Sugiyama | DYRK1A DYRK MNB MNBH | PAHYMTEGHLTMRQGADREEsPMtGVCVQQsPVAss_____ |
| Q13627 | S758 | Sugiyama | DYRK1A DYRK MNB MNBH | TMRQGADREEsPMtGVCVQQsPVAss_______________ |
| Q13627 | S97 | Sugiyama | DYRK1A DYRK MNB MNBH | LQRRMPQtFRDPAtAPLRKLsVDLIKTYKHINEVyYAKKKR |
| Q13627 | T751 | Sugiyama | DYRK1A DYRK MNB MNBH | YMTEGHLTMRQGADREEsPMtGVCVQQsPVAss________ |
| Q13627 | T84 | Sugiyama | DYRK1A DYRK MNB MNBH | QPLTNQVMPDIVMLQRRMPQtFRDPAtAPLRKLsVDLIKTY |
| Q13627 | T90 | Sugiyama | DYRK1A DYRK MNB MNBH | VMPDIVMLQRRMPQtFRDPAtAPLRKLsVDLIKTYKHINEV |
| Q13627 | Y111 | Sugiyama | DYRK1A DYRK MNB MNBH | APLRKLsVDLIKTYKHINEVyYAKKKRRHQQGQGDDSSHKK |
| Q13627 | Y136 | Sugiyama | DYRK1A DYRK MNB MNBH | KRRHQQGQGDDSSHKKERKVyNDGyDDDNyDyIVKNGEKWM |
| Q13627 | Y140 | Sugiyama | DYRK1A DYRK MNB MNBH | QQGQGDDSSHKKERKVyNDGyDDDNyDyIVKNGEKWMDRYE |
| Q13627 | Y319 | SIGNOR | DYRK1A DYRK MNB MNBH | KRSAIKIVDFGSSCQLGQRIyQyIQSRFYRSPEVLLGMPYD |
| Q13627 | Y321 | SIGNOR|EPSD|Sugiyama | DYRK1A DYRK MNB MNBH | SAIKIVDFGSSCQLGQRIyQyIQSRFYRSPEVLLGMPYDLA |
| Q14004 | S317 | Sugiyama | CDK13 CDC2L CDC2L5 CHED KIAA1791 | PKAYREDKTEPKAYRRRRsLsPLGGRDDsPVsHRASQSLRs |
| Q14004 | S325 | Sugiyama | CDK13 CDC2L CDC2L5 CHED KIAA1791 | TEPKAYRRRRsLsPLGGRDDsPVsHRASQSLRsRKsPsPAG |
| Q14157 | S477 | Sugiyama | UBAP2L KIAA0144 NICE4 | PsKstsAPQMsPGssDNQsssPQPAQQKLKQQKKKAsLTSK |
| Q14160 | S504 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | MKRSIEGRRsEACPCQPDsGsPLPAEEEKRLsAESGLSEDS |
| Q14247 | S405 | Sugiyama | CTTN EMS1 | EEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVyEDAA |
| Q14247 | T399 | Sugiyama | CTTN EMS1 | KERQEQEEARRKLEEQARAKtQtPPVsPAPQPtEERLPssP |
| Q14247 | T401 | Sugiyama | CTTN EMS1 | RQEQEEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVy |
| Q14258 | S100 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | DLAREPPADVWtPPARAsAPsPNAQVACDHCLKEAAVKTCL |
| Q14498 | S334 | Sugiyama | RBM39 HCC1 RNPC2 | FELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtT |
| Q14693 | S438 | Sugiyama | LPIN1 KIAA0188 | GDPSGLAKHASDNGARsANQsPQSVGSSGVDSGVESTSDGL |
| Q14814 | S251 | SIGNOR|PSP | MEF2D | sPGLLPVANGNsLNKVIPAKsPPPPtHstQLGAPSRKPDLR |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q15642 | S298 | Sugiyama | TRIP10 CIP4 STOT STP | RPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRSRT |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q52LA3 | S28 | SIGNOR|EPSD|PSP | LIN52 C14orf46 | PTDGTDLEASLLSFEKLDRAsPDLWPEQLPGVAEFAAsFKs |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q5JSH3 | S561 | Sugiyama | WDR44 RPH11 | KNAFDYFNNMRMKYNtEGRVsPsPsQEsLsssKsDTDtGVC |
| Q5T0N5 | S501 | Sugiyama | FNBP1L C1orf39 TOCA1 | GRGDRRHssDINHLVtQGREsPEGsytDDANQEVRGPPQQH |
| Q5T5Y3 | S563 | Sugiyama | CAMSAP1 | VAIVRADVVPQQADPEFPRAsPRALGLtANARsPQGQLDts |
| Q6GYQ0 | T1002 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | TITGSESASPVHSPLGSRsQtPsPSTLNIDHMEQKDLQLDE |
| Q6NW29 | S23 | Sugiyama | RWDD4 FAM28A RWDD4A | ANEDQEMELEALRSIyEGDEsFRELsPVSFQyRIGENGDPK |
| Q6NW29 | S28 | Sugiyama | RWDD4 FAM28A RWDD4A | EMELEALRSIyEGDEsFRELsPVSFQyRIGENGDPKAFLIE |
| Q6QNY0 | T16 | Sugiyama | BLOC1S3 BLOS3 | _____MASQGRRRRPLRRPEtVVPGEAtEtDsERsAsssEE |
| Q6UN15 | S492 | Sugiyama | FIP1L1 FIP1 RHE | DRDRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAE |
| Q6UN15 | S500 | Sugiyama | FIP1L1 FIP1 RHE | ERTRERERERDHsPtPsVFNsDEERyRYREYAERGYERHRA |
| Q6UN15 | T494 | Sugiyama | FIP1L1 FIP1 RHE | DRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAERG |
| Q71RC2 | S597 | Sugiyama | LARP4 PP13296 | QttIPVsPPsttKPsRAstAsPCNNNINAAtAVALQEPRKL |
| Q7LBC6 | S773 | Sugiyama | KDM3B C5orf7 JHDM2B JMJD1B KIAA1082 | GPGQQDNPLLKTFsNVFGRHsGGFLssPADFsQENKAPFEA |
| Q7Z2W4 | S378 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | NWKsLtsWtNDQGARRKtVFsPtLPAARssLGsLQtPEAVt |
| Q7Z2W4 | T273 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | FFQGsQEFLASASAsAERsCtPsPDQIsHRAsLEDAPVDDL |
| Q7Z5K2 | S221 | Sugiyama | WAPL FOE KIAA0261 WAPAL | AsEIKETNDTWNSQFGKRPEsPsEIsPIKGsVRTGLFEWDN |
| Q7Z5K2 | S223 | Sugiyama | WAPL FOE KIAA0261 WAPAL | EIKETNDTWNSQFGKRPEsPsEIsPIKGsVRTGLFEWDNDF |
| Q86TB9 | S179 | Sugiyama | PATL1 OK/KNS-cl.5 | PQGPEDDRDLSERALPRRstsPIIGsPPVRAVPIGtPPKQM |
| Q86VM9 | S607 | Sugiyama | ZC3H18 NHN1 | SRHSSFSGSRSRsRsFsssPsPsPtPsPHRPsIRTKGEPAP |
| Q86VM9 | S609 | Sugiyama | ZC3H18 NHN1 | HSSFSGSRSRsRsFsssPsPsPtPsPHRPsIRTKGEPAPPP |
| Q86WR0 | S187 | Sugiyama | CCDC25 | KKREKEEMKKKREMDELRSYssLMKVENMSSNQDGNDsDEF |
| Q86YP4 | S100 | Sugiyama | GATAD2A | DGPVDMRTSHSDMKSERRPPsPDVIVLsDNEQPssPRVNGL |
| Q8IWW6 | S240 | Sugiyama | ARHGAP12 | SSSsTEQIRAttPPNQGRPDsPVyANLQELKISQSALPPLP |
| Q8IWW6 | T230 | Sugiyama | ARHGAP12 | HQDSEsGDELSSSsTEQIRAttPPNQGRPDsPVyANLQELK |
| Q8IWW6 | T231 | Sugiyama | ARHGAP12 | QDSEsGDELSSSsTEQIRAttPPNQGRPDsPVyANLQELKI |
| Q8IWX8 | S815 | Sugiyama | CHERP DAN26 SCAF6 | RSQSRSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIP |
| Q8IWX8 | S817 | Sugiyama | CHERP DAN26 SCAF6 | QSRSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDS |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8N556 | S265 | Sugiyama | AFAP1 AFAP | KEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssDG |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8N6T3 | S343 | Sugiyama | ARFGAP1 ARF1GAP | NIDQSFWETFGSAEPTKtRKsPssDsWtCADtstERRssDs |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NBS9 | S292 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KKVDQYKGKRDLEsLREyVEsQLQRTETGATETVTPSEAPV |
| Q8ND56 | S183 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | GSAFTQDTRsLKtQLsQGRssPQLDPLRKsPtMEQAVQtAs |
| Q8TAD8 | S35 | Sugiyama | SNIP1 | RHRDGDVVLPAGVVVKQERLsPEVAPPAHRRPDHsGGsPsP |
| Q8TC07 | S675 | Sugiyama | TBC1D15 | TSAFQSNALPTLSASGARNDsPtQIPVssDVCRLtPA____ |
| Q8TDD1 | S624 | Sugiyama | DDX54 | FQQGQQGRQEQQEGPVGPAPsRPALQEKQPEKEEEEEAGEs |
| Q8TEW0 | S962 | Sugiyama | PARD3 PAR3 PAR3A | DEGMEtLEEDTEESSRsGREsVstAsDQPsHsLERQMNGNQ |
| Q8WW12 | T139 | Sugiyama | PCNP | sEPEEMPPEAKMRMKNIGRDtPtsAGPNsFNKGKHGFsDNQ |
| Q8WWM7 | S111 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | PGAAAIGsARGQstGKGPPQsPVFEGVyNNSRMLHFLTAVV |
| Q8WY36 | S844 | Sugiyama | BBX HBP2 | KRKARKTKITHLVRtADGRVsPAGGTLDDKPKEQLQRSLPK |
| Q8WZ42 | S20761 | Sugiyama | TTN | GGSPIINYVVQKRDAERKSWsTVTTECsKTSFRVANLEEGK |
| Q8WZ42 | S20768 | Sugiyama | TTN | YVVQKRDAERKSWsTVTTECsKTSFRVANLEEGKSYFFRVF |
| Q92499 | S481 | Sugiyama | DDX1 | KSHIRTDDVHAKDNTRPGANsPEMWSEAIKILKGEYAVRAI |
| Q92609 | S539 | Sugiyama | TBC1D5 KIAA0210 | KsEsMPVQLNKGLSSKNIsssPsVEsLPGGREFtGsPPssA |
| Q96B36 | S212 | Sugiyama | AKT1S1 PRAS40 | GFKEKRtEARssDEENGPPssPDLDRIAAsMRALVLREAED |
| Q96CW6 | S302 | Sugiyama | SLC7A6OS | SRQRMWSKYPLDVQKEFGyDsPHDLDsD_____________ |
| Q96D46 | S462 | Sugiyama | NMD3 CGI-07 | FLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRISLAE |
| Q96EB6 | T530 | GPS6|EPSD | SIRT1 SIR2L1 | ITEKPPRTQKELAYLSELPPtPLHVsEDsssPERtsPPDss |
| Q96EK9 | S184 | Sugiyama | KTI12 SBBI81 | GSAQADVPKELEREEsGAAEsPALVtPDSEKSAKHGsGAFy |
| Q96EN8 | S530 | Sugiyama | MOCOS | APSADSQADVIPAVMGRRsLsPQEDALTGSRVWNNSSTVNA |
| Q96GM8 | S420 | Sugiyama | TOE1 | KNDLEMGIKAARPEIADRATsEVPGsQAsPNPVPGDGLHRA |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96MH2 | T74 | Sugiyama | HEXIM2 L3 | EDEDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRR |
| Q96MU7 | S308 | Sugiyama | YTHDC1 KIAA1966 YT521 | GSGTDGsDEKKKERKRARGIsPIVFDRsGssAsESYAGsEK |
| Q96QT6 | T129 | Sugiyama | PHF12 KIAA1523 | REQKKELGHVNGLVDKSGKRttsPssDtDLLDRsAsKTELK |
| Q96S44 | T8 | Sugiyama | TP53RK C20orf64 PRPK | _____________MAAARAttPADGEEPAPEAEALAAARER |
| Q96S94 | S330 | SIGNOR|EPSD|PSP | CCNL2 SB138 | AQARGLLPGGTQVLDGtsGFsPAPKLVEsPKEGKGsKPsPL |
| Q96S94 | S338 | SIGNOR|iPTMNet|EPSD|PSP | CCNL2 SB138 | GGTQVLDGtsGFsPAPKLVEsPKEGKGsKPsPLSVKNTKRR |
| Q96S94 | S369 | SIGNOR|iPTMNet|EPSD|PSP | CCNL2 SB138 | PLSVKNTKRRLEGAKKAKADsPVNGLPKGRESRSRSRSREQ |
| Q99569 | S314 | Sugiyama | PKP4 | RQTSNPNGPTPQyQtTARVGsPLTLTDAQTRVAsPSQGQVG |
| Q99640 | S120 | Sugiyama | PKMYT1 MYT1 | sRPEsFFQQsFQRLSRLGHGsyGEVFKVRSKEDGRLYAVKR |
| Q99640 | Y121 | Sugiyama | PKMYT1 MYT1 | RPEsFFQQsFQRLSRLGHGsyGEVFKVRSKEDGRLYAVKRs |
| Q9BTA9 | S525 | Sugiyama | WAC KIAA1844 | QGHEPVsPRSLQRsssQRsPsPGPNHtsNssNAsNATVVPQ |
| Q9BY44 | T512 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | EAKKAAKQEARsDKsPDLAPtPAPQstPRNtVsQsIsGDPE |
| Q9BYG3 | T234 | Sugiyama | NIFK MKI67IP NOPP34 | KKKVsGtLDtPEKtVDsQGPtPVCtPtFLERRKsQVAELND |
| Q9BYG3 | T238 | Sugiyama | NIFK MKI67IP NOPP34 | sGtLDtPEKtVDsQGPtPVCtPtFLERRKsQVAELNDDDKD |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S1383 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | REHGVGGVsQCPEPGLRHNGsLsPGLEARDPLEARELGVGE |
| Q9C0C2 | S435 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | DAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQG |
| Q9C0C2 | S601 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LPLQQAEERyEsQEPLAGQEsPLPLATREAALPILEPVLGQ |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9C0D5 | S270 | Sugiyama | TANC1 KIAA1728 | GNLRLGVQKGVLHDRRADNCsPVAEEETTGsAEStLPKAES |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H4G0 | S784 | Sugiyama | EPB41L1 KIAA0338 | KGAAAMIPGPQTVATEIRsLsPIIGKDVLtstyGAtAEtLS |
| Q9H773 | S26 | Sugiyama | DCTPP1 XTP3TPA CDA03 | GEIRGDTGGEDTAAPGRFsFsPEPTLEDIRRLHAEFAAERD |
| Q9H7N4 | S498 | Sugiyama | SCAF1 SFRS19 SRA1 | GGLDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKK |
| Q9H7N4 | S500 | Sugiyama | SCAF1 SFRS19 SRA1 | LDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKKSR |
| Q9H7N4 | Y494 | Sugiyama | SCAF1 SFRS19 SRA1 | DSRWGGLDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPP |
| Q9HC35 | S146 | Sugiyama | EML4 C2orf2 EMAPL4 | REKKEEsHsNDQsPQIRAsPsPQPssQPLQIHRQtPEsKNA |
| Q9HCN4 | S301 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | ANAESQQQREQLERLRKDMGsVALDAGtAKDsLsPVLHPsD |
| Q9HDC5 | S413 | Sugiyama | JPH1 JP1 | QAALAARQECDIARAVARELsPDFyQPGPDyVKQRFQEGVD |
| Q9NPI6 | S525 | Sugiyama | DCP1A SMIF | SVFQQTVTRSSDLERKAssPsPLtIGtPEsQRKPSIILSKs |
| Q9NR19 | S30 | Sugiyama | ACSS2 ACAS2 | sGsGSRGQEEAGAGGRARsWsPPPEVsRSAHVPSLQRYREL |
| Q9NR28 | S230 | Sugiyama | DIABLO SMAC | EAQIEELRQKTQEEGEERAEsEQEAyLRED___________ |
| Q9NUQ3 | S97 | Sugiyama | TXLNG CXorf15 ELRG LSR5 | KHSLEEDEGsDFItENRNLVsPAyCtQEsREEIPGGEARTD |
| Q9NWB6 | S77 | Sugiyama | ARGLU1 | RsRstNTAVSRRERDRERAssPPDRIDIFGRTVSKRSSLDE |
| Q9NYV4 | S423 | Sugiyama | CDK12 CRK7 CRKRS KIAA0904 | KKERAAAAAAAKMDGKEsKGsPVFLPRKENSSVEAKDsGLE |
| Q9NYY3 | S358 | SIGNOR | PLK2 SNK | FTPDRLSSSCCHTVPDFHLSsPAKNFFKKAAAALFGGKKDK |
| Q9NZB2 | T991 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | PLQVVSVGGPARGRPRGVIstPVIRTFGRGGRYYGRGYKNQ |
| Q9P2R6 | S679 | Sugiyama | RERE ARG ARP ATN1L KIAA0458 | EEADRTSSKKTKTQEIsRPNsPsEGEGESSDSRsVNDEGSS |
| Q9UGV2 | S361 | Sugiyama | NDRG3 | sPFsRsVtsNQsDGtQESCEsPDVLDRHQTMEVsC______ |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UPQ0 | S212 | Sugiyama | LIMCH1 KIAA1102 | sPPRHGRDDsFDsLDsFGsRsRQtPsPDVVLRGssDGRGsD |
| Q9UPQ0 | S217 | Sugiyama | LIMCH1 KIAA1102 | GRDDsFDsLDsFGsRsRQtPsPDVVLRGssDGRGsDsEsDL |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S323 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RGEGDAPFsEPGttstQRPssPEtAtKQPssPYEDKDKDKK |
| Q9Y2K6 | S372 | Sugiyama | USP20 KIAA1003 LSFR3A VDU2 | tAMAALDDQPAEAQPPsPRsssPCRtPEPDNDAHLRSSsRP |
| Q9Y2K6 | T377 | Sugiyama | USP20 KIAA1003 LSFR3A VDU2 | LDDQPAEAQPPsPRsssPCRtPEPDNDAHLRSSsRPCsPVH |
| Q9Y2U5 | S164 | Sugiyama | MAP3K2 MAPKKK2 MEKK2 | FGAERKKRLsIIGPTSRDRssPPPGYIPDELHQVARNGSFT |
| Q9Y2V2 | S30 | Sugiyama | CARHSP1 | QPPtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRt |
| Q9Y2V2 | S32 | Sugiyama | CARHSP1 | PtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRtFs |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
| Q9Y3Z3 | T365 | Sugiyama | SAMHD1 MOP5 | NELRICARDKEVGNLYDMFHtRNSLHRRAYQHKVGNIIDTM |
| Q9Y463 | S49 | Sugiyama | DYRK1B MIRK | LPRRLPLAFRDATSAPLRKLsVDLIKTYKHINEVyYAKKKR |
| Q9Y463 | Y273 | Sugiyama | DYRK1B MIRK | SAIKIVDFGSSCQLGQRIyQyIQSRFYRSPEVLLGTPYDLA |
| Q9Y463 | Y63 | Sugiyama | DYRK1B MIRK | APLRKLsVDLIKTYKHINEVyYAKKKRRAQQAPPQDSSNKK |
| Q9Y6G9 | S516 | Sugiyama | DYNC1LI1 DNCLI1 | HAELDRITRKPVtVsPttPtsPtEGEAs_____________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 1.794074e-08 | 7.746 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.114492e-08 | 7.091 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.055530e-06 | 5.977 | 1 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.475191e-05 | 4.831 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.575259e-05 | 4.589 | 1 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.879583e-05 | 4.541 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.189868e-05 | 4.496 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.811373e-05 | 4.236 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.713850e-05 | 4.173 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.305512e-05 | 4.031 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.011368e-04 | 3.995 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.461566e-04 | 3.835 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.601640e-04 | 3.795 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.138615e-04 | 3.670 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.036080e-04 | 3.518 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.000782e-04 | 3.523 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.252921e-04 | 3.488 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.035598e-04 | 3.394 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.695351e-04 | 3.328 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.620136e-04 | 3.250 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.745922e-04 | 3.241 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.330542e-04 | 3.273 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.705383e-04 | 3.174 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 7.024405e-04 | 3.153 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.314408e-04 | 3.136 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 7.727976e-04 | 3.112 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.710823e-04 | 3.113 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.109978e-04 | 3.091 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.657126e-04 | 3.063 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.435880e-04 | 3.025 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.805827e-04 | 3.009 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.052646e-03 | 2.978 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.150286e-03 | 2.939 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.225505e-03 | 2.912 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.295196e-03 | 2.888 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.295196e-03 | 2.888 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.439917e-03 | 2.842 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.594752e-03 | 2.797 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.594752e-03 | 2.797 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.594752e-03 | 2.797 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.572952e-03 | 2.803 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.631391e-03 | 2.787 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.896208e-03 | 2.722 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.035255e-03 | 2.691 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.078131e-03 | 2.682 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.224001e-03 | 2.653 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.157225e-03 | 2.666 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 2.444448e-03 | 2.612 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.482942e-03 | 2.605 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.543110e-03 | 2.595 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.739426e-03 | 2.562 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.915320e-03 | 2.535 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.052025e-03 | 2.515 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.106019e-03 | 2.508 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.130571e-03 | 2.504 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.455764e-03 | 2.461 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.485447e-03 | 2.458 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.522906e-03 | 2.453 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.426138e-03 | 2.354 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.475137e-03 | 2.349 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.576670e-03 | 2.339 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.712443e-03 | 2.327 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.360991e-03 | 2.271 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.360991e-03 | 2.271 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.378862e-03 | 2.269 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.929552e-03 | 2.307 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.929552e-03 | 2.307 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.146378e-03 | 2.288 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.929552e-03 | 2.307 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.672788e-03 | 2.246 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.064768e-03 | 2.217 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.064768e-03 | 2.217 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.072852e-03 | 2.217 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.885381e-03 | 2.162 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 7.356718e-03 | 2.133 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.356718e-03 | 2.133 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.356718e-03 | 2.133 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.397509e-03 | 2.131 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.687393e-03 | 2.114 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.824190e-03 | 2.107 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 8.561551e-03 | 2.067 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 8.561551e-03 | 2.067 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 8.561551e-03 | 2.067 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 8.677393e-03 | 2.062 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.949951e-03 | 2.048 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 8.949951e-03 | 2.048 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.175885e-03 | 2.037 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.501875e-03 | 2.022 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 9.991620e-03 | 2.000 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 9.938174e-03 | 2.003 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 9.536684e-03 | 2.021 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.013003e-02 | 1.994 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.038439e-02 | 1.984 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.063254e-02 | 1.973 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.145462e-02 | 1.941 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.093059e-02 | 1.961 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.142826e-02 | 1.942 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 1.087828e-02 | 1.963 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.074493e-02 | 1.969 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.158727e-02 | 1.936 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.179865e-02 | 1.928 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.198995e-02 | 1.921 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.198995e-02 | 1.921 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.280577e-02 | 1.893 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.280577e-02 | 1.893 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.282247e-02 | 1.892 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.282247e-02 | 1.892 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.280577e-02 | 1.893 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.316159e-02 | 1.881 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.316159e-02 | 1.881 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.316159e-02 | 1.881 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.316159e-02 | 1.881 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.515599e-02 | 1.819 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.531071e-02 | 1.815 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.502026e-02 | 1.823 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.442136e-02 | 1.841 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.595410e-02 | 1.797 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.610926e-02 | 1.793 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.614085e-02 | 1.792 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.664700e-02 | 1.779 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.734872e-02 | 1.761 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.694930e-02 | 1.771 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.749442e-02 | 1.757 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.739439e-02 | 1.760 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.791655e-02 | 1.747 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.835834e-02 | 1.736 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.871961e-02 | 1.728 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.871961e-02 | 1.728 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.899342e-02 | 1.721 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.949875e-02 | 1.710 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.949875e-02 | 1.710 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.033171e-02 | 1.692 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.075555e-02 | 1.683 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.081866e-02 | 1.682 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.030925e-02 | 1.692 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.956302e-02 | 1.709 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.114851e-02 | 1.675 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.154130e-02 | 1.667 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.215823e-02 | 1.654 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.464751e-02 | 1.608 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.407169e-02 | 1.618 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.407169e-02 | 1.618 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.407169e-02 | 1.618 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.407169e-02 | 1.618 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.407169e-02 | 1.618 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.462137e-02 | 1.609 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.511505e-02 | 1.600 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.338883e-02 | 1.631 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.417730e-02 | 1.617 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.417730e-02 | 1.617 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.531880e-02 | 1.597 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.541152e-02 | 1.595 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.542684e-02 | 1.595 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.555462e-02 | 1.593 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.555462e-02 | 1.593 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.980672e-02 | 1.526 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.888672e-02 | 1.539 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.026538e-02 | 1.519 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.026538e-02 | 1.519 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.980672e-02 | 1.526 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.895373e-02 | 1.538 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.895373e-02 | 1.538 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.895373e-02 | 1.538 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.895373e-02 | 1.538 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.923973e-02 | 1.534 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.895373e-02 | 1.538 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.135151e-02 | 1.504 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 3.142823e-02 | 1.503 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 3.142823e-02 | 1.503 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.171200e-02 | 1.499 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.171200e-02 | 1.499 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.205972e-02 | 1.494 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.205972e-02 | 1.494 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.205972e-02 | 1.494 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.223941e-02 | 1.492 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.236680e-02 | 1.490 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.246089e-02 | 1.489 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.261710e-02 | 1.487 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.309118e-02 | 1.480 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.343581e-02 | 1.476 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.520759e-02 | 1.453 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.664416e-02 | 1.436 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.724150e-02 | 1.429 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.438686e-02 | 1.464 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.520759e-02 | 1.453 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.727752e-02 | 1.429 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.425308e-02 | 1.465 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.846913e-02 | 1.415 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.923166e-02 | 1.406 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.998444e-02 | 1.398 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.006333e-02 | 1.397 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.006333e-02 | 1.397 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.131306e-02 | 1.384 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.163081e-02 | 1.381 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.190933e-02 | 1.378 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.190933e-02 | 1.378 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.217379e-02 | 1.375 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.361516e-02 | 1.360 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.400746e-02 | 1.356 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.060821e-02 | 1.296 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.576328e-02 | 1.339 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.777520e-02 | 1.321 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.042344e-02 | 1.297 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.006930e-02 | 1.300 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.865440e-02 | 1.313 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.671260e-02 | 1.331 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.990625e-02 | 1.302 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.056926e-02 | 1.296 | 1 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.949260e-02 | 1.305 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.949260e-02 | 1.305 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.627129e-02 | 1.335 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.709500e-02 | 1.327 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.952882e-02 | 1.305 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.627129e-02 | 1.335 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.677747e-02 | 1.330 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.082062e-02 | 1.294 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.082062e-02 | 1.294 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.301814e-02 | 1.276 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.323511e-02 | 1.274 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.471566e-02 | 1.262 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.522578e-02 | 1.258 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.551953e-02 | 1.256 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.762715e-02 | 1.239 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.801074e-02 | 1.236 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.801074e-02 | 1.236 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.801074e-02 | 1.236 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 6.470801e-02 | 1.189 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 6.470801e-02 | 1.189 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.679577e-02 | 1.175 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.679577e-02 | 1.175 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.679577e-02 | 1.175 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.679577e-02 | 1.175 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.679577e-02 | 1.175 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.028615e-02 | 1.220 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.995577e-02 | 1.222 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.539629e-02 | 1.184 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.539629e-02 | 1.184 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.995577e-02 | 1.222 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.028615e-02 | 1.220 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.028615e-02 | 1.220 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.031797e-02 | 1.220 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.028615e-02 | 1.220 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.917130e-02 | 1.160 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.838724e-02 | 1.165 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.637766e-02 | 1.178 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.038577e-02 | 1.219 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.407555e-02 | 1.193 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.308114e-02 | 1.200 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.969487e-02 | 1.157 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.052187e-02 | 1.152 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.100354e-02 | 1.149 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.195310e-02 | 1.143 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.195310e-02 | 1.143 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.234388e-02 | 1.141 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 7.317489e-02 | 1.136 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 7.317489e-02 | 1.136 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 7.317489e-02 | 1.136 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.380523e-02 | 1.132 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.380523e-02 | 1.132 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.380523e-02 | 1.132 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.380523e-02 | 1.132 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.380523e-02 | 1.132 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 7.537154e-02 | 1.123 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.608031e-02 | 1.119 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.638898e-02 | 1.117 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.715207e-02 | 1.113 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.720176e-02 | 1.112 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.720176e-02 | 1.112 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 8.533665e-02 | 1.069 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 8.756260e-02 | 1.058 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 8.756260e-02 | 1.058 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.877956e-02 | 1.052 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.280711e-02 | 1.082 | 1 | 1 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.280711e-02 | 1.082 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.632439e-02 | 1.064 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.626638e-02 | 1.017 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 8.367728e-02 | 1.077 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 8.367728e-02 | 1.077 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.139372e-02 | 1.039 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 8.395786e-02 | 1.076 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.358884e-02 | 1.078 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.280711e-02 | 1.082 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.280711e-02 | 1.082 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.634854e-02 | 1.064 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.756260e-02 | 1.058 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.328631e-02 | 1.030 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 9.328631e-02 | 1.030 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 9.328631e-02 | 1.030 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.449846e-02 | 1.073 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.139372e-02 | 1.039 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 8.573931e-02 | 1.067 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.476230e-02 | 1.023 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 8.111792e-02 | 1.091 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.642601e-02 | 1.016 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.747133e-02 | 1.011 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 9.748148e-02 | 1.011 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.813454e-02 | 1.008 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 9.813454e-02 | 1.008 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.841006e-02 | 1.007 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 9.911725e-02 | 1.004 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.911725e-02 | 1.004 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 9.912254e-02 | 1.004 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 9.912254e-02 | 1.004 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 9.912254e-02 | 1.004 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 9.912254e-02 | 1.004 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 9.928453e-02 | 1.003 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.954009e-02 | 1.002 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.003705e-01 | 0.998 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.003705e-01 | 0.998 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.006834e-01 | 0.997 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.045041e-01 | 0.981 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.047834e-01 | 0.980 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.047834e-01 | 0.980 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.052640e-01 | 0.978 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.053587e-01 | 0.977 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.053821e-01 | 0.977 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.053821e-01 | 0.977 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.053821e-01 | 0.977 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.053821e-01 | 0.977 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.053821e-01 | 0.977 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.053821e-01 | 0.977 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.053821e-01 | 0.977 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.053821e-01 | 0.977 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.053821e-01 | 0.977 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.053821e-01 | 0.977 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.053821e-01 | 0.977 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.134356e-01 | 0.945 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.143829e-01 | 0.942 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.282441e-01 | 0.892 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.282441e-01 | 0.892 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.282441e-01 | 0.892 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.282441e-01 | 0.892 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.282441e-01 | 0.892 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.281811e-01 | 0.892 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.281811e-01 | 0.892 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.288948e-01 | 0.890 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.288948e-01 | 0.890 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.288948e-01 | 0.890 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.288948e-01 | 0.890 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.437163e-01 | 0.842 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.437163e-01 | 0.842 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.230513e-01 | 0.910 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.270164e-01 | 0.896 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.424088e-01 | 0.846 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.424088e-01 | 0.846 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.298783e-01 | 0.886 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.291853e-01 | 0.889 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.341754e-01 | 0.872 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.424687e-01 | 0.846 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.187331e-01 | 0.925 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.249689e-01 | 0.903 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 1.437163e-01 | 0.842 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.195233e-01 | 0.923 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.270164e-01 | 0.896 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 1.281811e-01 | 0.892 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.265860e-01 | 0.898 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.437163e-01 | 0.842 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.235351e-01 | 0.908 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.298783e-01 | 0.886 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.299388e-01 | 0.886 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.437163e-01 | 0.842 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.475450e-01 | 0.831 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 1.510082e-01 | 0.821 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.510082e-01 | 0.821 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.510082e-01 | 0.821 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.513839e-01 | 0.820 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.535254e-01 | 0.814 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.535254e-01 | 0.814 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.535254e-01 | 0.814 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.542380e-01 | 0.812 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.551354e-01 | 0.809 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.551354e-01 | 0.809 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.554741e-01 | 0.808 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.598295e-01 | 0.796 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.598295e-01 | 0.796 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.598295e-01 | 0.796 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.598295e-01 | 0.796 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 1.598295e-01 | 0.796 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 1.598295e-01 | 0.796 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.598295e-01 | 0.796 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.606392e-01 | 0.794 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.636648e-01 | 0.786 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.636648e-01 | 0.786 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.645061e-01 | 0.784 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.650783e-01 | 0.782 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.652082e-01 | 0.782 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.652082e-01 | 0.782 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.652082e-01 | 0.782 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.652082e-01 | 0.782 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.400480e-01 | 0.620 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.400480e-01 | 0.620 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.400480e-01 | 0.620 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.400480e-01 | 0.620 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.400480e-01 | 0.620 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.400480e-01 | 0.620 | 0 | 0 |
| Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) | R-HSA-9036092 | 2.400480e-01 | 0.620 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.400480e-01 | 0.620 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.400480e-01 | 0.620 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.996486e-01 | 0.700 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.996486e-01 | 0.700 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.996486e-01 | 0.700 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.996486e-01 | 0.700 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.375187e-01 | 0.472 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.375187e-01 | 0.472 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.375187e-01 | 0.472 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.375187e-01 | 0.472 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.375187e-01 | 0.472 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.375187e-01 | 0.472 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.375187e-01 | 0.472 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.375187e-01 | 0.472 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.375187e-01 | 0.472 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.375187e-01 | 0.472 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.375187e-01 | 0.472 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.375187e-01 | 0.472 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.375187e-01 | 0.472 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.497806e-01 | 0.602 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.497806e-01 | 0.602 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.497806e-01 | 0.602 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.497806e-01 | 0.602 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 1.935388e-01 | 0.713 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.935388e-01 | 0.713 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.797564e-01 | 0.745 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.797564e-01 | 0.745 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.797564e-01 | 0.745 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.797564e-01 | 0.745 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.797564e-01 | 0.745 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.797564e-01 | 0.745 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.287947e-01 | 0.641 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.287947e-01 | 0.641 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.287947e-01 | 0.641 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.287947e-01 | 0.641 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.287947e-01 | 0.641 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.002224e-01 | 0.523 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.002224e-01 | 0.523 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.002224e-01 | 0.523 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.002224e-01 | 0.523 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.002224e-01 | 0.523 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.224927e-01 | 0.374 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 4.224927e-01 | 0.374 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 4.224927e-01 | 0.374 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 4.224927e-01 | 0.374 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.224927e-01 | 0.374 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.073446e-01 | 0.683 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.878789e-01 | 0.726 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.705456e-01 | 0.768 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.360414e-01 | 0.627 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.500703e-01 | 0.456 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.500703e-01 | 0.456 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.500703e-01 | 0.456 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.906516e-01 | 0.720 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.020457e-01 | 0.520 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.020457e-01 | 0.520 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.020457e-01 | 0.520 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 3.020457e-01 | 0.520 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.655999e-01 | 0.576 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.655999e-01 | 0.576 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.655999e-01 | 0.576 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.361838e-01 | 0.627 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.906254e-01 | 0.720 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.906254e-01 | 0.720 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.615188e-01 | 0.582 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.957796e-01 | 0.529 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.957796e-01 | 0.529 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.391939e-01 | 0.470 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.391939e-01 | 0.470 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.391939e-01 | 0.470 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.986472e-01 | 0.399 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.986472e-01 | 0.399 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.986472e-01 | 0.399 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.986472e-01 | 0.399 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 3.986472e-01 | 0.399 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.986472e-01 | 0.399 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.986472e-01 | 0.399 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 3.986472e-01 | 0.399 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.965718e-01 | 0.304 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 4.965718e-01 | 0.304 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.965718e-01 | 0.304 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.965718e-01 | 0.304 | 0 | 0 |
| Defective GSS causes GSS deficiency | R-HSA-5579006 | 4.965718e-01 | 0.304 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.965718e-01 | 0.304 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.965718e-01 | 0.304 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.290258e-01 | 0.640 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.874403e-01 | 0.541 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.022958e-01 | 0.694 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.263508e-01 | 0.486 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.263508e-01 | 0.486 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.785915e-01 | 0.555 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.762031e-01 | 0.425 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.132039e-01 | 0.671 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.355600e-01 | 0.628 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.355600e-01 | 0.628 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.355600e-01 | 0.628 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.019433e-01 | 0.520 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.019433e-01 | 0.520 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.570979e-01 | 0.447 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.223096e-01 | 0.653 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.706125e-01 | 0.568 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.256333e-01 | 0.487 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.256333e-01 | 0.487 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.127672e-01 | 0.384 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.127672e-01 | 0.384 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.871342e-01 | 0.728 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.878213e-01 | 0.411 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.878213e-01 | 0.411 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.672529e-01 | 0.435 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.672529e-01 | 0.435 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.495595e-01 | 0.456 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.339318e-01 | 0.476 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.198790e-01 | 0.495 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.070784e-01 | 0.513 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.126813e-01 | 0.505 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.736226e-01 | 0.428 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.940772e-01 | 0.404 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.940772e-01 | 0.404 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.940772e-01 | 0.404 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.183393e-01 | 0.378 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.183393e-01 | 0.378 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.183393e-01 | 0.378 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.486261e-01 | 0.348 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.901607e-01 | 0.310 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.611521e-01 | 0.251 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.611521e-01 | 0.251 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.611521e-01 | 0.251 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.611521e-01 | 0.251 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.611521e-01 | 0.251 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.611521e-01 | 0.251 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.317242e-01 | 0.635 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.302829e-01 | 0.481 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.302829e-01 | 0.481 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.778404e-01 | 0.423 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.284554e-01 | 0.484 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 4.835637e-01 | 0.316 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.835637e-01 | 0.316 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.835637e-01 | 0.316 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.835637e-01 | 0.316 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.835637e-01 | 0.316 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.457049e-01 | 0.351 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.781247e-01 | 0.320 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 5.325223e-01 | 0.274 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.325223e-01 | 0.274 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.402082e-01 | 0.356 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.174048e-01 | 0.286 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.623956e-01 | 0.335 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.592934e-01 | 0.338 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.928331e-01 | 0.307 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.873589e-01 | 0.312 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.825593e-01 | 0.316 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.970791e-01 | 0.304 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.245286e-01 | 0.280 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.500111e-01 | 0.260 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.500111e-01 | 0.260 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 6.174513e-01 | 0.209 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.174513e-01 | 0.209 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.174513e-01 | 0.209 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.174513e-01 | 0.209 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.174513e-01 | 0.209 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.174513e-01 | 0.209 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.174513e-01 | 0.209 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.174513e-01 | 0.209 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.046511e-01 | 0.297 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.157033e-01 | 0.288 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 5.627870e-01 | 0.250 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.627870e-01 | 0.250 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.607313e-01 | 0.251 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.732878e-01 | 0.242 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.795758e-01 | 0.237 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.823955e-01 | 0.235 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.097587e-01 | 0.215 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.905385e-01 | 0.229 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.905385e-01 | 0.229 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.979622e-01 | 0.223 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.979622e-01 | 0.223 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.048220e-01 | 0.218 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.111307e-01 | 0.214 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.111307e-01 | 0.214 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.148270e-01 | 0.211 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.439003e-01 | 0.191 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 6.445658e-01 | 0.191 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.445658e-01 | 0.191 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.445658e-01 | 0.191 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 6.445658e-01 | 0.191 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 6.445658e-01 | 0.191 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.445658e-01 | 0.191 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.445658e-01 | 0.191 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.628302e-01 | 0.179 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.628302e-01 | 0.179 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.505022e-01 | 0.601 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.977274e-01 | 0.400 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.213802e-01 | 0.283 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.213802e-01 | 0.283 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 3.263508e-01 | 0.486 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.591777e-01 | 0.586 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.198790e-01 | 0.495 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.439003e-01 | 0.191 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.404496e-01 | 0.468 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.878213e-01 | 0.411 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.411581e-01 | 0.193 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.711300e-01 | 0.430 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.071219e-01 | 0.295 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.711300e-01 | 0.430 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.711300e-01 | 0.430 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.393069e-01 | 0.268 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.127672e-01 | 0.384 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.192942e-01 | 0.208 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.245286e-01 | 0.280 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.484886e-01 | 0.348 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.325223e-01 | 0.274 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.563945e-01 | 0.341 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.797564e-01 | 0.745 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.445658e-01 | 0.191 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.886930e-01 | 0.540 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.886930e-01 | 0.540 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.778404e-01 | 0.423 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.878213e-01 | 0.411 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.198790e-01 | 0.495 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 3.570979e-01 | 0.447 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.038232e-01 | 0.691 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.486261e-01 | 0.348 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.492264e-01 | 0.260 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.216542e-01 | 0.206 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.083504e-01 | 0.216 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.092360e-01 | 0.510 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.287947e-01 | 0.641 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.325223e-01 | 0.274 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.097587e-01 | 0.215 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 3.019433e-01 | 0.520 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.445658e-01 | 0.191 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.878213e-01 | 0.411 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.602481e-01 | 0.585 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 2.651123e-01 | 0.577 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 2.655999e-01 | 0.576 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.019433e-01 | 0.520 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.454595e-01 | 0.351 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.865377e-01 | 0.729 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.999930e-01 | 0.523 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.840291e-01 | 0.416 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.325223e-01 | 0.274 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.346802e-01 | 0.362 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.517889e-01 | 0.345 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.328932e-01 | 0.364 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.290258e-01 | 0.640 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.099147e-01 | 0.678 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.438660e-01 | 0.464 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.585275e-01 | 0.253 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.097587e-01 | 0.215 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.736226e-01 | 0.428 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.273072e-01 | 0.369 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.375187e-01 | 0.472 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.906516e-01 | 0.720 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.022958e-01 | 0.694 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.454595e-01 | 0.351 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.672529e-01 | 0.435 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.153064e-01 | 0.667 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.345270e-01 | 0.630 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.901607e-01 | 0.310 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.611521e-01 | 0.251 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 4.835637e-01 | 0.316 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.734887e-01 | 0.325 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.353727e-01 | 0.271 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 5.500111e-01 | 0.260 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.379321e-01 | 0.269 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.504262e-01 | 0.601 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.504262e-01 | 0.601 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.724363e-01 | 0.763 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.858190e-01 | 0.414 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.192942e-01 | 0.208 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.509737e-01 | 0.346 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.660370e-01 | 0.332 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.038232e-01 | 0.691 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.271396e-01 | 0.644 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.325223e-01 | 0.274 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.648113e-01 | 0.333 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.445658e-01 | 0.191 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.157033e-01 | 0.288 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.700918e-01 | 0.244 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.796621e-01 | 0.553 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.207991e-01 | 0.376 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.732878e-01 | 0.242 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.393961e-01 | 0.357 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.891967e-01 | 0.230 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.433563e-01 | 0.265 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.497806e-01 | 0.602 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.287947e-01 | 0.641 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 2.615188e-01 | 0.582 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 6.174513e-01 | 0.209 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.174513e-01 | 0.209 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.174513e-01 | 0.209 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.627870e-01 | 0.250 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 6.097587e-01 | 0.215 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 5.979622e-01 | 0.223 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.126094e-01 | 0.213 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.087087e-01 | 0.294 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.201050e-01 | 0.657 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.843538e-01 | 0.315 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.613899e-01 | 0.583 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.613899e-01 | 0.583 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.886930e-01 | 0.540 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.623956e-01 | 0.335 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.558234e-01 | 0.449 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.928137e-01 | 0.227 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.367540e-01 | 0.196 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.325223e-01 | 0.274 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.669182e-01 | 0.574 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.478041e-01 | 0.189 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.996486e-01 | 0.700 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.797564e-01 | 0.745 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.797564e-01 | 0.745 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.797564e-01 | 0.745 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 3.002224e-01 | 0.523 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 4.965718e-01 | 0.304 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.785915e-01 | 0.555 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.724090e-01 | 0.242 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.226329e-01 | 0.491 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.140969e-01 | 0.669 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.478041e-01 | 0.189 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.856531e-01 | 0.731 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.939299e-01 | 0.226 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.076651e-01 | 0.294 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.500703e-01 | 0.456 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.874403e-01 | 0.541 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.186820e-01 | 0.660 | 0 | 0 |
| Vasopressin-like receptors | R-HSA-388479 | 5.611521e-01 | 0.251 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.287731e-01 | 0.202 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.395204e-01 | 0.194 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.641972e-01 | 0.578 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.272194e-01 | 0.369 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.127082e-01 | 0.290 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.076651e-01 | 0.294 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.098904e-01 | 0.293 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.397385e-01 | 0.357 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 2.360414e-01 | 0.627 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.790535e-01 | 0.554 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.589526e-01 | 0.338 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.678025e-01 | 0.434 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 5.892912e-01 | 0.230 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.884707e-01 | 0.311 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.502812e-01 | 0.602 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.493819e-01 | 0.260 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.148270e-01 | 0.211 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.000801e-01 | 0.301 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.840291e-01 | 0.416 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.926456e-01 | 0.227 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.795412e-01 | 0.237 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.439280e-01 | 0.353 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.277293e-01 | 0.369 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.277293e-01 | 0.369 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.277293e-01 | 0.369 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.497806e-01 | 0.602 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.497806e-01 | 0.602 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 3.002224e-01 | 0.523 | 0 | 0 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 4.224927e-01 | 0.374 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.224927e-01 | 0.374 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.224927e-01 | 0.374 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.360414e-01 | 0.627 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.500703e-01 | 0.456 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.094960e-01 | 0.679 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.965718e-01 | 0.304 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 4.965718e-01 | 0.304 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.965718e-01 | 0.304 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.454595e-01 | 0.351 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.127672e-01 | 0.384 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.901607e-01 | 0.310 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.611521e-01 | 0.251 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.611521e-01 | 0.251 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.835637e-01 | 0.316 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.071219e-01 | 0.295 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.743584e-01 | 0.324 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.724090e-01 | 0.242 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.174513e-01 | 0.209 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 6.174513e-01 | 0.209 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 6.174513e-01 | 0.209 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.538286e-01 | 0.257 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.538286e-01 | 0.257 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.732878e-01 | 0.242 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.159395e-01 | 0.210 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.577780e-01 | 0.182 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.411581e-01 | 0.193 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.093958e-01 | 0.388 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.046511e-01 | 0.297 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.849150e-01 | 0.415 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.093882e-01 | 0.509 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.393504e-01 | 0.194 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.486261e-01 | 0.348 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.863694e-01 | 0.232 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 2.651123e-01 | 0.577 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.432265e-01 | 0.192 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.724836e-01 | 0.763 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.655999e-01 | 0.576 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.333200e-01 | 0.632 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.333200e-01 | 0.632 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.772172e-01 | 0.751 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.878789e-01 | 0.726 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.812780e-01 | 0.236 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.812780e-01 | 0.236 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.840127e-01 | 0.315 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.300145e-01 | 0.638 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.611521e-01 | 0.251 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.473043e-01 | 0.349 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.148270e-01 | 0.211 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.325223e-01 | 0.274 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.174048e-01 | 0.286 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.843871e-01 | 0.734 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.843871e-01 | 0.734 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.048220e-01 | 0.218 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.475872e-01 | 0.349 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.622225e-01 | 0.179 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.454595e-01 | 0.351 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.611521e-01 | 0.251 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 5.325223e-01 | 0.274 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.109091e-01 | 0.676 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.046511e-01 | 0.297 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 2.287947e-01 | 0.641 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.148270e-01 | 0.211 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.109091e-01 | 0.676 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.229401e-01 | 0.206 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.807124e-01 | 0.419 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.401021e-01 | 0.356 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.375187e-01 | 0.472 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 2.651123e-01 | 0.577 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.965718e-01 | 0.304 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.137989e-01 | 0.503 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.127672e-01 | 0.384 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.878213e-01 | 0.411 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.486261e-01 | 0.348 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.611521e-01 | 0.251 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 4.484886e-01 | 0.348 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.781247e-01 | 0.320 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.325223e-01 | 0.274 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.724090e-01 | 0.242 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.892912e-01 | 0.230 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.393504e-01 | 0.194 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.423595e-01 | 0.616 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.935388e-01 | 0.713 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.287947e-01 | 0.641 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.628302e-01 | 0.179 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.287947e-01 | 0.641 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.901607e-01 | 0.310 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.835637e-01 | 0.316 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.439280e-01 | 0.353 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.111307e-01 | 0.214 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.471163e-01 | 0.189 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.253482e-01 | 0.280 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.886930e-01 | 0.540 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.986472e-01 | 0.399 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.454595e-01 | 0.351 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.611521e-01 | 0.251 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.611521e-01 | 0.251 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 6.097587e-01 | 0.215 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.192942e-01 | 0.208 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.393504e-01 | 0.194 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.781247e-01 | 0.320 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.395204e-01 | 0.194 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.504234e-01 | 0.259 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.463278e-01 | 0.461 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.851952e-01 | 0.545 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.707172e-01 | 0.567 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.395204e-01 | 0.194 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.171554e-01 | 0.380 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.111307e-01 | 0.214 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.497806e-01 | 0.602 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 5.611521e-01 | 0.251 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.174513e-01 | 0.209 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 6.445658e-01 | 0.191 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.148270e-01 | 0.211 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.812780e-01 | 0.236 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.951758e-01 | 0.305 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.297264e-01 | 0.276 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.591777e-01 | 0.586 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.174513e-01 | 0.209 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.381038e-01 | 0.195 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.445658e-01 | 0.191 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.753475e-01 | 0.756 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.174513e-01 | 0.209 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 6.631407e-01 | 0.178 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.631407e-01 | 0.178 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.640809e-01 | 0.178 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.664207e-01 | 0.176 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.664207e-01 | 0.176 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.664207e-01 | 0.176 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.664207e-01 | 0.176 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.665308e-01 | 0.176 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.665308e-01 | 0.176 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.665308e-01 | 0.176 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.665308e-01 | 0.176 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.665308e-01 | 0.176 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.665308e-01 | 0.176 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.665308e-01 | 0.176 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.665308e-01 | 0.176 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.665308e-01 | 0.176 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.665308e-01 | 0.176 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.665308e-01 | 0.176 | 0 | 0 |
| Ligand-receptor interactions | R-HSA-5632681 | 6.665308e-01 | 0.176 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.665308e-01 | 0.176 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.665308e-01 | 0.176 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.665308e-01 | 0.176 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.665308e-01 | 0.176 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 6.665308e-01 | 0.176 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.665308e-01 | 0.176 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.665308e-01 | 0.176 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.665308e-01 | 0.176 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 6.768679e-01 | 0.169 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.768679e-01 | 0.169 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.768679e-01 | 0.169 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.789733e-01 | 0.168 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.821530e-01 | 0.166 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.823227e-01 | 0.166 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.823227e-01 | 0.166 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.852467e-01 | 0.164 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.869817e-01 | 0.163 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.918246e-01 | 0.160 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.918246e-01 | 0.160 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.918246e-01 | 0.160 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.918246e-01 | 0.160 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.963327e-01 | 0.157 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.985398e-01 | 0.156 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.988173e-01 | 0.156 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.988173e-01 | 0.156 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 6.989737e-01 | 0.156 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.996096e-01 | 0.155 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.996096e-01 | 0.155 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.016501e-01 | 0.154 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.018782e-01 | 0.154 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.018782e-01 | 0.154 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.018782e-01 | 0.154 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.025461e-01 | 0.153 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.065907e-01 | 0.151 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.065907e-01 | 0.151 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.065907e-01 | 0.151 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.065907e-01 | 0.151 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.067348e-01 | 0.151 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.067348e-01 | 0.151 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.067348e-01 | 0.151 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.067348e-01 | 0.151 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.093161e-01 | 0.149 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.093161e-01 | 0.149 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.093161e-01 | 0.149 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 7.093161e-01 | 0.149 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 7.093161e-01 | 0.149 | 0 | 0 |
| Agmatine biosynthesis | R-HSA-351143 | 7.093161e-01 | 0.149 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.093161e-01 | 0.149 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.093161e-01 | 0.149 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 7.093161e-01 | 0.149 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.145617e-01 | 0.146 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.148987e-01 | 0.146 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.148987e-01 | 0.146 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.157415e-01 | 0.145 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.157415e-01 | 0.145 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.157415e-01 | 0.145 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.157415e-01 | 0.145 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 7.204490e-01 | 0.142 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 7.204490e-01 | 0.142 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 7.204490e-01 | 0.142 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.268623e-01 | 0.139 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.268623e-01 | 0.139 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.278606e-01 | 0.138 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.279636e-01 | 0.138 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 7.287324e-01 | 0.137 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.333276e-01 | 0.135 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.333276e-01 | 0.135 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.333276e-01 | 0.135 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.342595e-01 | 0.134 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.342595e-01 | 0.134 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 7.342595e-01 | 0.134 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.342595e-01 | 0.134 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.342595e-01 | 0.134 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.342595e-01 | 0.134 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 7.342595e-01 | 0.134 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.342595e-01 | 0.134 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.375745e-01 | 0.132 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.381941e-01 | 0.132 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.381941e-01 | 0.132 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.466140e-01 | 0.127 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 7.466140e-01 | 0.127 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.466140e-01 | 0.127 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.466140e-01 | 0.127 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.466140e-01 | 0.127 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.466140e-01 | 0.127 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.466140e-01 | 0.127 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.466140e-01 | 0.127 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.466140e-01 | 0.127 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.466140e-01 | 0.127 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.466140e-01 | 0.127 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.466140e-01 | 0.127 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.466140e-01 | 0.127 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.525854e-01 | 0.123 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.540134e-01 | 0.123 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.550694e-01 | 0.122 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.592161e-01 | 0.120 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.592161e-01 | 0.120 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.595514e-01 | 0.119 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 7.595514e-01 | 0.119 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 7.595514e-01 | 0.119 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.595514e-01 | 0.119 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.598023e-01 | 0.119 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.629254e-01 | 0.118 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.629254e-01 | 0.118 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.638389e-01 | 0.117 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.642264e-01 | 0.117 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.642264e-01 | 0.117 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.642711e-01 | 0.117 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.642711e-01 | 0.117 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.711312e-01 | 0.113 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.711312e-01 | 0.113 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.711312e-01 | 0.113 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.732659e-01 | 0.112 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.739065e-01 | 0.111 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.788501e-01 | 0.109 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.788501e-01 | 0.109 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.788761e-01 | 0.109 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.788761e-01 | 0.109 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 7.791281e-01 | 0.108 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.791281e-01 | 0.108 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.791281e-01 | 0.108 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.791281e-01 | 0.108 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.791281e-01 | 0.108 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.791281e-01 | 0.108 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.791281e-01 | 0.108 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.791281e-01 | 0.108 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.791281e-01 | 0.108 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.791281e-01 | 0.108 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.791281e-01 | 0.108 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.813544e-01 | 0.107 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.813544e-01 | 0.107 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.813544e-01 | 0.107 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.820670e-01 | 0.107 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.827300e-01 | 0.106 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.827300e-01 | 0.106 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 7.827300e-01 | 0.106 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 7.827300e-01 | 0.106 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.827300e-01 | 0.106 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 7.827300e-01 | 0.106 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 7.827300e-01 | 0.106 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 7.827300e-01 | 0.106 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.828235e-01 | 0.106 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.863760e-01 | 0.104 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.863760e-01 | 0.104 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.904603e-01 | 0.102 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.904603e-01 | 0.102 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.943556e-01 | 0.100 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.971453e-01 | 0.098 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.974787e-01 | 0.098 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.974787e-01 | 0.098 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.008195e-01 | 0.096 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.008195e-01 | 0.096 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.008195e-01 | 0.096 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.024917e-01 | 0.096 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.039213e-01 | 0.095 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.039213e-01 | 0.095 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.039213e-01 | 0.095 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.039213e-01 | 0.095 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.039213e-01 | 0.095 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.039213e-01 | 0.095 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.074119e-01 | 0.093 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.074119e-01 | 0.093 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 8.074717e-01 | 0.093 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 8.074717e-01 | 0.093 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.074717e-01 | 0.093 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 8.074717e-01 | 0.093 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 8.074717e-01 | 0.093 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 8.074717e-01 | 0.093 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.074717e-01 | 0.093 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 8.074717e-01 | 0.093 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 8.074717e-01 | 0.093 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 8.074717e-01 | 0.093 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 8.074717e-01 | 0.093 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.074717e-01 | 0.093 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 8.074717e-01 | 0.093 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.109919e-01 | 0.091 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.126289e-01 | 0.090 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.126289e-01 | 0.090 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.126289e-01 | 0.090 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.126289e-01 | 0.090 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.141563e-01 | 0.089 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.141563e-01 | 0.089 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.141563e-01 | 0.089 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.144804e-01 | 0.089 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.167109e-01 | 0.088 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.180124e-01 | 0.087 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.180124e-01 | 0.087 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.203993e-01 | 0.086 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.232535e-01 | 0.084 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.232535e-01 | 0.084 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.232535e-01 | 0.084 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.232535e-01 | 0.084 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.268377e-01 | 0.083 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 8.299413e-01 | 0.081 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.299413e-01 | 0.081 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.299413e-01 | 0.081 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 8.299413e-01 | 0.081 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.299413e-01 | 0.081 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 8.299413e-01 | 0.081 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.299413e-01 | 0.081 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.301730e-01 | 0.081 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.321795e-01 | 0.080 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.321795e-01 | 0.080 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 8.321795e-01 | 0.080 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 8.321795e-01 | 0.080 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.321795e-01 | 0.080 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.321795e-01 | 0.080 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.321795e-01 | 0.080 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.321795e-01 | 0.080 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.321795e-01 | 0.080 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 8.321795e-01 | 0.080 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.323310e-01 | 0.080 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.382108e-01 | 0.077 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.395414e-01 | 0.076 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.395414e-01 | 0.076 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.401402e-01 | 0.076 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.401402e-01 | 0.076 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.401402e-01 | 0.076 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.401402e-01 | 0.076 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.408547e-01 | 0.075 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.408547e-01 | 0.075 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.408547e-01 | 0.075 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.408547e-01 | 0.075 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.408547e-01 | 0.075 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.408547e-01 | 0.075 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.408547e-01 | 0.075 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.408547e-01 | 0.075 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.408547e-01 | 0.075 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.409288e-01 | 0.075 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.410021e-01 | 0.075 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.425689e-01 | 0.074 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.431956e-01 | 0.074 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.436374e-01 | 0.074 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.469597e-01 | 0.072 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.470366e-01 | 0.072 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.497198e-01 | 0.071 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.509897e-01 | 0.070 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.509897e-01 | 0.070 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.509897e-01 | 0.070 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.515835e-01 | 0.070 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.525734e-01 | 0.069 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.525734e-01 | 0.069 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.529494e-01 | 0.069 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.537177e-01 | 0.069 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.537177e-01 | 0.069 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.537177e-01 | 0.069 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.537177e-01 | 0.069 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.537177e-01 | 0.069 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 8.537177e-01 | 0.069 | 0 | 0 |
| Hormone ligand-binding receptors | R-HSA-375281 | 8.537177e-01 | 0.069 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.537177e-01 | 0.069 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.537177e-01 | 0.069 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.537177e-01 | 0.069 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.537177e-01 | 0.069 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.537177e-01 | 0.069 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.546267e-01 | 0.068 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.568506e-01 | 0.067 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.568506e-01 | 0.067 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.568506e-01 | 0.067 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.568506e-01 | 0.067 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.568506e-01 | 0.067 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.580762e-01 | 0.066 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.580762e-01 | 0.066 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.580762e-01 | 0.066 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.580762e-01 | 0.066 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.601354e-01 | 0.065 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.602298e-01 | 0.065 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.617507e-01 | 0.065 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.705503e-01 | 0.060 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.710153e-01 | 0.060 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.710153e-01 | 0.060 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.710153e-01 | 0.060 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.710153e-01 | 0.060 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.713634e-01 | 0.060 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.713634e-01 | 0.060 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.718517e-01 | 0.060 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.724927e-01 | 0.059 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.724927e-01 | 0.059 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.724927e-01 | 0.059 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.724927e-01 | 0.059 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.724927e-01 | 0.059 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.724927e-01 | 0.059 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.724927e-01 | 0.059 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.724927e-01 | 0.059 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.724927e-01 | 0.059 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.724927e-01 | 0.059 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.749861e-01 | 0.058 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.751780e-01 | 0.058 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.792933e-01 | 0.056 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.813201e-01 | 0.055 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.820447e-01 | 0.055 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.820447e-01 | 0.055 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.820447e-01 | 0.055 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.845101e-01 | 0.053 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.845101e-01 | 0.053 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 8.845101e-01 | 0.053 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.845101e-01 | 0.053 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.850214e-01 | 0.053 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.850440e-01 | 0.053 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.850440e-01 | 0.053 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.850440e-01 | 0.053 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.850440e-01 | 0.053 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.882755e-01 | 0.051 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.888590e-01 | 0.051 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.888590e-01 | 0.051 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.888590e-01 | 0.051 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.888590e-01 | 0.051 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.888590e-01 | 0.051 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.888590e-01 | 0.051 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.888590e-01 | 0.051 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.888590e-01 | 0.051 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.888590e-01 | 0.051 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.888590e-01 | 0.051 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.901841e-01 | 0.051 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.926205e-01 | 0.049 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.926205e-01 | 0.049 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.943886e-01 | 0.048 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.943886e-01 | 0.048 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.964023e-01 | 0.047 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.964023e-01 | 0.047 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.964023e-01 | 0.047 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.964023e-01 | 0.047 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 8.964023e-01 | 0.047 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.966235e-01 | 0.047 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.984717e-01 | 0.046 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.992864e-01 | 0.046 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.023370e-01 | 0.045 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.023370e-01 | 0.045 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.030590e-01 | 0.044 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.030590e-01 | 0.044 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 9.031254e-01 | 0.044 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 9.031254e-01 | 0.044 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.031254e-01 | 0.044 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 9.031254e-01 | 0.044 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.031254e-01 | 0.044 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.031254e-01 | 0.044 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 9.031254e-01 | 0.044 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 9.031254e-01 | 0.044 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.054811e-01 | 0.043 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.071454e-01 | 0.042 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.071454e-01 | 0.042 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.071454e-01 | 0.042 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 9.071454e-01 | 0.042 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.071454e-01 | 0.042 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.089493e-01 | 0.041 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.089493e-01 | 0.041 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.104660e-01 | 0.041 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.104660e-01 | 0.041 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.110934e-01 | 0.040 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.110934e-01 | 0.040 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.110934e-01 | 0.040 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.112521e-01 | 0.040 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.112521e-01 | 0.040 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.134299e-01 | 0.039 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.134299e-01 | 0.039 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.144034e-01 | 0.039 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.155612e-01 | 0.038 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 9.155612e-01 | 0.038 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.155612e-01 | 0.038 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.155612e-01 | 0.038 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.155612e-01 | 0.038 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.155612e-01 | 0.038 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.156535e-01 | 0.038 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.168383e-01 | 0.038 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.168383e-01 | 0.038 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.185294e-01 | 0.037 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.194212e-01 | 0.036 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.194212e-01 | 0.036 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.222935e-01 | 0.035 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.230429e-01 | 0.035 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.246549e-01 | 0.034 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.254033e-01 | 0.034 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.254033e-01 | 0.034 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.255736e-01 | 0.034 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.255736e-01 | 0.034 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.255736e-01 | 0.034 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.255736e-01 | 0.034 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.255736e-01 | 0.034 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 9.264013e-01 | 0.033 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.264013e-01 | 0.033 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 9.264013e-01 | 0.033 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.264013e-01 | 0.033 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.264013e-01 | 0.033 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.264013e-01 | 0.033 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.264013e-01 | 0.033 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 9.264013e-01 | 0.033 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.264013e-01 | 0.033 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 9.264013e-01 | 0.033 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 9.264013e-01 | 0.033 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.264013e-01 | 0.033 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.264147e-01 | 0.033 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.268976e-01 | 0.033 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.268976e-01 | 0.033 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.268976e-01 | 0.033 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.268976e-01 | 0.033 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.287295e-01 | 0.032 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.317504e-01 | 0.031 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.317504e-01 | 0.031 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.317504e-01 | 0.031 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.317504e-01 | 0.031 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 9.334373e-01 | 0.030 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.334373e-01 | 0.030 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.334373e-01 | 0.030 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.334373e-01 | 0.030 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.334373e-01 | 0.030 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.337320e-01 | 0.030 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.340421e-01 | 0.030 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.358503e-01 | 0.029 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.358503e-01 | 0.029 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.358503e-01 | 0.029 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 9.358503e-01 | 0.029 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.358503e-01 | 0.029 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.358503e-01 | 0.029 | 0 | 0 |
| Mineralocorticoid biosynthesis | R-HSA-193993 | 9.358503e-01 | 0.029 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.365671e-01 | 0.028 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.366450e-01 | 0.028 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.376047e-01 | 0.028 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.378376e-01 | 0.028 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.384820e-01 | 0.028 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.390005e-01 | 0.027 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.399725e-01 | 0.027 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.399725e-01 | 0.027 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.405093e-01 | 0.027 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.405093e-01 | 0.027 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.405093e-01 | 0.027 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.405734e-01 | 0.027 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 9.420309e-01 | 0.026 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.426514e-01 | 0.026 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.436241e-01 | 0.025 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.440867e-01 | 0.025 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.440867e-01 | 0.025 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.440867e-01 | 0.025 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.440867e-01 | 0.025 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.440867e-01 | 0.025 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.440867e-01 | 0.025 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.440867e-01 | 0.025 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.450614e-01 | 0.025 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.456647e-01 | 0.024 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.456647e-01 | 0.024 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.456647e-01 | 0.024 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 9.464880e-01 | 0.024 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.468630e-01 | 0.024 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.468630e-01 | 0.024 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.468630e-01 | 0.024 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.468630e-01 | 0.024 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.468630e-01 | 0.024 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.472985e-01 | 0.024 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.500360e-01 | 0.022 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.508516e-01 | 0.022 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.508516e-01 | 0.022 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.508516e-01 | 0.022 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.512402e-01 | 0.022 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.512660e-01 | 0.022 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.512660e-01 | 0.022 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.512660e-01 | 0.022 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.512660e-01 | 0.022 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.512660e-01 | 0.022 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.512660e-01 | 0.022 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.516017e-01 | 0.022 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.519038e-01 | 0.021 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.519038e-01 | 0.021 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.525288e-01 | 0.021 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.525665e-01 | 0.021 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.525665e-01 | 0.021 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.525665e-01 | 0.021 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.525665e-01 | 0.021 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.525665e-01 | 0.021 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.532875e-01 | 0.021 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.555732e-01 | 0.020 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.555732e-01 | 0.020 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.555732e-01 | 0.020 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.555732e-01 | 0.020 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.564551e-01 | 0.019 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.565155e-01 | 0.019 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.565155e-01 | 0.019 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.567227e-01 | 0.019 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.574188e-01 | 0.019 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.575238e-01 | 0.019 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.575238e-01 | 0.019 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.575238e-01 | 0.019 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.575238e-01 | 0.019 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.575238e-01 | 0.019 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.576818e-01 | 0.019 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.594298e-01 | 0.018 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.598674e-01 | 0.018 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.598674e-01 | 0.018 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.605720e-01 | 0.017 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 9.622659e-01 | 0.017 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.622659e-01 | 0.017 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.622659e-01 | 0.017 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.623505e-01 | 0.017 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.626613e-01 | 0.017 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.626613e-01 | 0.017 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.629784e-01 | 0.016 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.629784e-01 | 0.016 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.629784e-01 | 0.016 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.629784e-01 | 0.016 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.637694e-01 | 0.016 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.641019e-01 | 0.016 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.662073e-01 | 0.015 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.662073e-01 | 0.015 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.663709e-01 | 0.015 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.677328e-01 | 0.014 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.677328e-01 | 0.014 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.677328e-01 | 0.014 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.677328e-01 | 0.014 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.686888e-01 | 0.014 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.700442e-01 | 0.013 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.705254e-01 | 0.013 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.706631e-01 | 0.013 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.706631e-01 | 0.013 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.713527e-01 | 0.013 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.718769e-01 | 0.012 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.718769e-01 | 0.012 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.718769e-01 | 0.012 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.718769e-01 | 0.012 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.718769e-01 | 0.012 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.728890e-01 | 0.012 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.730049e-01 | 0.012 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.731737e-01 | 0.012 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.733289e-01 | 0.012 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.733289e-01 | 0.012 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.733289e-01 | 0.012 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.734381e-01 | 0.012 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.749899e-01 | 0.011 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.751672e-01 | 0.011 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.752282e-01 | 0.011 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.754803e-01 | 0.011 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.754889e-01 | 0.011 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.754889e-01 | 0.011 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.754889e-01 | 0.011 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.754889e-01 | 0.011 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.754889e-01 | 0.011 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.754889e-01 | 0.011 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.756332e-01 | 0.011 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.760763e-01 | 0.011 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.762643e-01 | 0.010 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.762643e-01 | 0.010 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.762643e-01 | 0.010 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.762643e-01 | 0.010 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.762643e-01 | 0.010 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.770341e-01 | 0.010 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.772556e-01 | 0.010 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.772556e-01 | 0.010 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.777411e-01 | 0.010 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.781345e-01 | 0.010 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.786373e-01 | 0.009 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.786373e-01 | 0.009 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.786373e-01 | 0.009 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.786373e-01 | 0.009 | 0 | 0 |
| Reactions specific to the complex N-glycan synthesis pathway | R-HSA-975578 | 9.786373e-01 | 0.009 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.786373e-01 | 0.009 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.786373e-01 | 0.009 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.786373e-01 | 0.009 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.786373e-01 | 0.009 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.786373e-01 | 0.009 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.788859e-01 | 0.009 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.788859e-01 | 0.009 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.789047e-01 | 0.009 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.812258e-01 | 0.008 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.812258e-01 | 0.008 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.813814e-01 | 0.008 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.813814e-01 | 0.008 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.813814e-01 | 0.008 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.813814e-01 | 0.008 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.815465e-01 | 0.008 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.815465e-01 | 0.008 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.815465e-01 | 0.008 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.816191e-01 | 0.008 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.816864e-01 | 0.008 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.817171e-01 | 0.008 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.818562e-01 | 0.008 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.819798e-01 | 0.008 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.825749e-01 | 0.008 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.827510e-01 | 0.008 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.833131e-01 | 0.007 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.833131e-01 | 0.007 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.834015e-01 | 0.007 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.834015e-01 | 0.007 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.835654e-01 | 0.007 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.835654e-01 | 0.007 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.837685e-01 | 0.007 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.837731e-01 | 0.007 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.837731e-01 | 0.007 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.837731e-01 | 0.007 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.837731e-01 | 0.007 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.837731e-01 | 0.007 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.843377e-01 | 0.007 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.847492e-01 | 0.007 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.847492e-01 | 0.007 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.849636e-01 | 0.007 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.849636e-01 | 0.007 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.851741e-01 | 0.006 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.856331e-01 | 0.006 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.857076e-01 | 0.006 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.858525e-01 | 0.006 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.858577e-01 | 0.006 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.858577e-01 | 0.006 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.858577e-01 | 0.006 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.858577e-01 | 0.006 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.858577e-01 | 0.006 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.858577e-01 | 0.006 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.858577e-01 | 0.006 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.859800e-01 | 0.006 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.859800e-01 | 0.006 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.863854e-01 | 0.006 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.874421e-01 | 0.005 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.876747e-01 | 0.005 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.881466e-01 | 0.005 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.881466e-01 | 0.005 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.883096e-01 | 0.005 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.888544e-01 | 0.005 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.892582e-01 | 0.005 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.892582e-01 | 0.005 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.892582e-01 | 0.005 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.892582e-01 | 0.005 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.892582e-01 | 0.005 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.892582e-01 | 0.005 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.895660e-01 | 0.005 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.896022e-01 | 0.005 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.900327e-01 | 0.004 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.900464e-01 | 0.004 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.903346e-01 | 0.004 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.906384e-01 | 0.004 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.906384e-01 | 0.004 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.906384e-01 | 0.004 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.906384e-01 | 0.004 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.906384e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.907949e-01 | 0.004 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.907949e-01 | 0.004 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.907949e-01 | 0.004 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.908738e-01 | 0.004 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.912844e-01 | 0.004 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.913968e-01 | 0.004 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.917725e-01 | 0.004 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.918357e-01 | 0.004 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.918357e-01 | 0.004 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.918357e-01 | 0.004 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.918414e-01 | 0.004 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.926687e-01 | 0.003 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.928335e-01 | 0.003 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.928335e-01 | 0.003 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.928898e-01 | 0.003 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.928898e-01 | 0.003 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.934634e-01 | 0.003 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.934643e-01 | 0.003 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.935567e-01 | 0.003 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.935644e-01 | 0.003 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.935836e-01 | 0.003 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.938035e-01 | 0.003 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.938035e-01 | 0.003 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.941024e-01 | 0.003 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.943143e-01 | 0.002 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.945140e-01 | 0.002 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.945438e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.945438e-01 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.945687e-01 | 0.002 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.947919e-01 | 0.002 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.949495e-01 | 0.002 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.952907e-01 | 0.002 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.952940e-01 | 0.002 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.952940e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.952940e-01 | 0.002 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.954882e-01 | 0.002 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.955393e-01 | 0.002 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.957675e-01 | 0.002 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.958989e-01 | 0.002 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.959728e-01 | 0.002 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.960505e-01 | 0.002 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.960505e-01 | 0.002 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.960539e-01 | 0.002 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.960946e-01 | 0.002 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.962678e-01 | 0.002 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.962798e-01 | 0.002 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.964043e-01 | 0.002 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.964260e-01 | 0.002 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.964260e-01 | 0.002 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.964260e-01 | 0.002 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.964260e-01 | 0.002 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.964260e-01 | 0.002 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.964260e-01 | 0.002 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.964260e-01 | 0.002 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.964651e-01 | 0.002 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.965041e-01 | 0.002 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.965041e-01 | 0.002 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.966052e-01 | 0.001 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.967683e-01 | 0.001 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.967683e-01 | 0.001 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.968600e-01 | 0.001 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.968855e-01 | 0.001 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.968855e-01 | 0.001 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.968855e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.971346e-01 | 0.001 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.971714e-01 | 0.001 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.972859e-01 | 0.001 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.972859e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.976079e-01 | 0.001 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.976348e-01 | 0.001 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.977832e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.978580e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.978580e-01 | 0.001 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.978591e-01 | 0.001 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.978976e-01 | 0.001 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.979183e-01 | 0.001 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.979389e-01 | 0.001 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.979389e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.979527e-01 | 0.001 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.980884e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.981451e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.982039e-01 | 0.001 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.982039e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.982039e-01 | 0.001 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.982348e-01 | 0.001 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.982685e-01 | 0.001 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.983269e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.983454e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.984060e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.984349e-01 | 0.001 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.984349e-01 | 0.001 | 0 | 0 |
| N-glycan antennae elongation in the medial/trans-Golgi | R-HSA-975576 | 9.984349e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.984788e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.986361e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.986436e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.986936e-01 | 0.001 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.988115e-01 | 0.001 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.988460e-01 | 0.001 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.989085e-01 | 0.000 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.989644e-01 | 0.000 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.989644e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.989807e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.990421e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.991000e-01 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.991000e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.991000e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.991000e-01 | 0.000 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.992136e-01 | 0.000 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.992136e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.992136e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.992826e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.993148e-01 | 0.000 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.993148e-01 | 0.000 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.993262e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.993563e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.993776e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.993809e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.993965e-01 | 0.000 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.994029e-01 | 0.000 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.994029e-01 | 0.000 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.994029e-01 | 0.000 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.994537e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.994629e-01 | 0.000 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.994798e-01 | 0.000 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.995467e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.996050e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.996118e-01 | 0.000 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.996226e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.996250e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.996250e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.996558e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.996571e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.996571e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.996694e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.996847e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.997001e-01 | 0.000 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.997001e-01 | 0.000 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.997001e-01 | 0.000 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.997387e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.997723e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.997735e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.997853e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.997886e-01 | 0.000 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.998189e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998241e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.998272e-01 | 0.000 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.998634e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.998634e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.998688e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.998734e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.998738e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.998843e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.998982e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.998989e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.999004e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999067e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999067e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999179e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999283e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999346e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.999500e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999500e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999501e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999574e-01 | 0.000 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.999608e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.999650e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999653e-01 | 0.000 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.999682e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999771e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999810e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999810e-01 | 0.000 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.999829e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999830e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.999834e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999834e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.999880e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999901e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999907e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999920e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999952e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999966e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999968e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999979e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999979e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999984e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999987e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999989e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999990e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999991e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999992e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999996e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999996e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999996e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999996e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999997e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.999998e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999999e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.000000e+00 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 0.000002 | 5.724 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 0.000002 | 5.765 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 0.000002 | 5.618 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 0.000004 | 5.377 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 0.000005 | 5.281 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 0.000009 | 5.044 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 0.000009 | 5.048 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 0.000011 | 4.974 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 0.000012 | 4.936 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 0.000012 | 4.908 | 1 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 0.000013 | 4.875 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 0.000016 | 4.783 | 1 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 0.000020 | 4.688 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 0.000022 | 4.648 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 0.000022 | 4.648 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 0.000029 | 4.541 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 0.000029 | 4.541 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 0.000033 | 4.486 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 0.000035 | 4.459 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 0.000036 | 4.438 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 0.000039 | 4.410 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 0.000040 | 4.394 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 0.000042 | 4.377 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 0.000043 | 4.362 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 0.000046 | 4.338 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 0.000057 | 4.241 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 0.000071 | 4.148 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 0.000088 | 4.056 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 0.000116 | 3.937 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 0.000116 | 3.937 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 0.000131 | 3.882 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 0.000130 | 3.887 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 0.000159 | 3.799 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 0.000191 | 3.718 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 0.000226 | 3.645 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 0.000214 | 3.669 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 0.000229 | 3.639 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 0.000229 | 3.639 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 0.000226 | 3.645 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 0.000274 | 3.563 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 0.000286 | 3.543 | 0 | 0 |
| M Phase | R-HSA-68886 | 0.000326 | 3.487 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 0.000359 | 3.445 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 0.000381 | 3.419 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 0.000396 | 3.402 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 0.000434 | 3.363 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 0.000447 | 3.349 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 0.000509 | 3.294 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 0.000497 | 3.303 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 0.000544 | 3.264 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 0.000576 | 3.239 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 0.000618 | 3.209 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 0.000640 | 3.194 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 0.000633 | 3.198 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 0.000718 | 3.144 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 0.000718 | 3.144 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 0.000859 | 3.066 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 0.000859 | 3.066 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 0.000856 | 3.068 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 0.000912 | 3.040 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 0.000958 | 3.019 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 0.001050 | 2.979 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 0.001050 | 2.979 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 0.001026 | 2.989 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 0.001086 | 2.964 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 0.001125 | 2.949 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 0.001420 | 2.848 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 0.001408 | 2.851 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 0.001379 | 2.860 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 0.001471 | 2.832 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 0.001529 | 2.816 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 0.001801 | 2.745 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 0.002062 | 2.686 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 0.002417 | 2.617 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 0.002444 | 2.612 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 0.002444 | 2.612 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 0.002444 | 2.612 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 0.002525 | 2.598 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 0.002618 | 2.582 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 0.002444 | 2.612 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 0.002751 | 2.561 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 0.003014 | 2.521 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 0.003134 | 2.504 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 0.003638 | 2.439 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 0.003773 | 2.423 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 0.003773 | 2.423 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 0.003801 | 2.420 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 0.003976 | 2.401 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 0.004012 | 2.397 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 0.004151 | 2.382 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 0.004151 | 2.382 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 0.004161 | 2.381 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 0.004597 | 2.338 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 0.004473 | 2.349 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 0.004716 | 2.326 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 0.005061 | 2.296 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 0.005154 | 2.288 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 0.005302 | 2.276 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 0.005302 | 2.276 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 0.005302 | 2.276 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 0.005663 | 2.247 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 0.006509 | 2.186 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 0.006754 | 2.170 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 0.006801 | 2.167 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 0.007124 | 2.147 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 0.007124 | 2.147 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 0.007124 | 2.147 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 0.007124 | 2.147 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 0.007124 | 2.147 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 0.007155 | 2.145 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 0.007155 | 2.145 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 0.007688 | 2.114 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 0.007519 | 2.124 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 0.008163 | 2.088 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 0.007519 | 2.124 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 0.008509 | 2.070 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 0.008522 | 2.069 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 0.008836 | 2.054 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 0.008849 | 2.053 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 0.009088 | 2.042 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 0.009492 | 2.023 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 0.009950 | 2.002 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 0.009950 | 2.002 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 0.010274 | 1.988 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 0.010453 | 1.981 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 0.010649 | 1.973 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 0.010649 | 1.973 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 0.011034 | 1.957 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 0.012135 | 1.916 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 0.012143 | 1.916 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 0.012143 | 1.916 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 0.012596 | 1.900 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 0.013455 | 1.871 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 0.013784 | 1.861 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 0.015120 | 1.820 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 0.015533 | 1.809 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 0.015120 | 1.820 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 0.015120 | 1.820 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 0.015388 | 1.813 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 0.014193 | 1.848 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 0.014039 | 1.853 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 0.015443 | 1.811 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 0.014541 | 1.837 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 0.016604 | 1.780 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 0.016604 | 1.780 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 0.018016 | 1.744 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 0.018658 | 1.729 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 0.018658 | 1.729 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 0.018681 | 1.729 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 0.018809 | 1.726 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 0.019314 | 1.714 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 0.019386 | 1.713 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 0.019519 | 1.710 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 0.019631 | 1.707 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 0.022670 | 1.645 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 0.022670 | 1.645 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 0.024195 | 1.616 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 0.024583 | 1.609 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 0.022472 | 1.648 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 0.024221 | 1.616 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 0.024570 | 1.610 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 0.025014 | 1.602 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 0.025325 | 1.596 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 0.025325 | 1.596 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 0.025325 | 1.596 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 0.025464 | 1.594 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 0.025920 | 1.586 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 0.026267 | 1.581 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 0.026712 | 1.573 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 0.026843 | 1.571 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 0.028244 | 1.549 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 0.028535 | 1.545 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 0.028535 | 1.545 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 0.028908 | 1.539 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 0.032226 | 1.492 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 0.034602 | 1.461 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 0.031449 | 1.502 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 0.031851 | 1.497 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 0.032226 | 1.492 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 0.036530 | 1.437 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 0.032623 | 1.486 | 0 | 0 |
| S Phase | R-HSA-69242 | 0.034150 | 1.467 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 0.035859 | 1.445 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 0.031449 | 1.502 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 0.035718 | 1.447 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 0.035306 | 1.452 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 0.032226 | 1.492 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 0.032936 | 1.482 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 0.037113 | 1.430 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 0.037656 | 1.424 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 0.038534 | 1.414 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 0.039416 | 1.404 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 0.039701 | 1.401 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 0.039711 | 1.401 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 0.040006 | 1.398 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 0.040006 | 1.398 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 0.041274 | 1.384 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 0.042758 | 1.369 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 0.043116 | 1.365 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 0.043657 | 1.360 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 0.043657 | 1.360 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 0.043657 | 1.360 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 0.043657 | 1.360 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 0.044838 | 1.348 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 0.044990 | 1.347 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 0.054522 | 1.263 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 0.054522 | 1.263 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 0.048643 | 1.313 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 0.046056 | 1.337 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 0.046852 | 1.329 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 0.048643 | 1.313 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 0.051409 | 1.289 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 0.048643 | 1.313 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 0.051682 | 1.287 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 0.048643 | 1.313 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 0.054137 | 1.267 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 0.046362 | 1.334 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 0.051682 | 1.287 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 0.046056 | 1.337 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 0.053465 | 1.272 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 0.050532 | 1.296 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 0.048643 | 1.313 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 0.049738 | 1.303 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 0.048651 | 1.313 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 0.055262 | 1.258 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 0.057171 | 1.243 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 0.057722 | 1.239 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 0.060151 | 1.221 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 0.060330 | 1.219 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 0.060330 | 1.219 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 0.063488 | 1.197 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 0.063488 | 1.197 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 0.063771 | 1.195 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 0.064325 | 1.192 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 0.064675 | 1.189 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 0.065700 | 1.182 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 0.067049 | 1.174 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 0.068377 | 1.165 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 0.068377 | 1.165 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 0.069461 | 1.158 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 0.069632 | 1.157 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 0.070547 | 1.152 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 0.071301 | 1.147 | 0 | 0 |
| IRS activation | R-HSA-74713 | 0.071301 | 1.147 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 0.071301 | 1.147 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 0.071301 | 1.147 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 0.072666 | 1.139 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 0.079401 | 1.100 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 0.079401 | 1.100 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 0.076682 | 1.115 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 0.084408 | 1.074 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 0.090099 | 1.045 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 0.091236 | 1.040 | 1 | 1 |
| DNA strand elongation | R-HSA-69190 | 0.091236 | 1.040 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 0.074472 | 1.128 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 0.089498 | 1.048 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 0.091141 | 1.040 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 0.087147 | 1.060 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 0.076213 | 1.118 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 0.076213 | 1.118 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 0.079401 | 1.100 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 0.091141 | 1.040 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 0.088629 | 1.052 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 0.087649 | 1.057 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 0.089498 | 1.048 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 0.073043 | 1.136 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 0.074744 | 1.126 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 0.073043 | 1.136 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 0.076682 | 1.115 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 0.091141 | 1.040 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 0.073043 | 1.136 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 0.093468 | 1.029 | 1 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 0.095226 | 1.021 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 0.095347 | 1.021 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 0.099447 | 1.002 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 0.102091 | 0.991 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 0.102112 | 0.991 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 0.103304 | 0.986 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 0.103552 | 0.985 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 0.106146 | 0.974 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 0.107105 | 0.970 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 0.108429 | 0.965 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 0.109260 | 0.962 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 0.116586 | 0.933 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 0.116586 | 0.933 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 0.116586 | 0.933 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 0.116586 | 0.933 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 0.116586 | 0.933 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 0.117023 | 0.932 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 0.117023 | 0.932 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 0.119488 | 0.923 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 0.119488 | 0.923 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 0.119488 | 0.923 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 0.122274 | 0.913 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 0.124124 | 0.906 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 0.124124 | 0.906 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 0.124224 | 0.906 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 0.125737 | 0.901 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 0.128212 | 0.892 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 0.170300 | 0.769 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 0.170300 | 0.769 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 0.170300 | 0.769 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 0.220364 | 0.657 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 0.220364 | 0.657 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 0.220364 | 0.657 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 0.220364 | 0.657 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 0.129240 | 0.889 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 0.129240 | 0.889 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 0.129240 | 0.889 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 0.267411 | 0.573 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 0.267411 | 0.573 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 0.267411 | 0.573 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 0.267411 | 0.573 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 0.172154 | 0.764 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 0.172154 | 0.764 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 0.311621 | 0.506 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 0.311621 | 0.506 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 0.311621 | 0.506 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 0.311621 | 0.506 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 0.311621 | 0.506 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 0.311621 | 0.506 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 0.311621 | 0.506 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 0.311621 | 0.506 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 0.311621 | 0.506 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 0.194389 | 0.711 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 0.130196 | 0.885 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 0.216956 | 0.664 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 0.353166 | 0.452 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 0.189400 | 0.723 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 0.262618 | 0.581 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 0.262618 | 0.581 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 0.262618 | 0.581 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 0.392206 | 0.406 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 0.392206 | 0.406 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 0.392206 | 0.406 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 0.392206 | 0.406 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 0.392206 | 0.406 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 0.392206 | 0.406 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 0.392206 | 0.406 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 0.392206 | 0.406 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 0.392206 | 0.406 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 0.392206 | 0.406 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 0.152460 | 0.817 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 0.152460 | 0.817 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 0.152460 | 0.817 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 0.205148 | 0.688 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 0.285510 | 0.544 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 0.133229 | 0.875 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 0.176136 | 0.754 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 0.308326 | 0.511 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 0.308326 | 0.511 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 0.428892 | 0.368 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 0.428892 | 0.368 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 0.171964 | 0.765 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 0.330992 | 0.480 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 0.270539 | 0.568 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 0.270539 | 0.568 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 0.270539 | 0.568 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 0.287274 | 0.542 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 0.353444 | 0.452 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 0.353444 | 0.452 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 0.463365 | 0.334 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 0.463365 | 0.334 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 0.463365 | 0.334 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 0.463365 | 0.334 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 0.463365 | 0.334 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 0.463365 | 0.334 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 0.158145 | 0.801 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 0.158145 | 0.801 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 0.182155 | 0.740 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 0.320934 | 0.494 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 0.397484 | 0.401 | 0 | 0 |
| RSK activation | R-HSA-444257 | 0.495760 | 0.305 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 0.495760 | 0.305 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 0.495760 | 0.305 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 0.495760 | 0.305 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 0.495760 | 0.305 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 0.495760 | 0.305 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 0.354620 | 0.450 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 0.354620 | 0.450 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 0.354620 | 0.450 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 0.243357 | 0.614 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 0.371394 | 0.430 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 0.335844 | 0.474 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 0.307118 | 0.513 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 0.261937 | 0.582 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 0.260555 | 0.584 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 0.331243 | 0.480 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 0.363761 | 0.439 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 0.363761 | 0.439 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 0.363761 | 0.439 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 0.391625 | 0.407 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 0.392063 | 0.407 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 0.419305 | 0.377 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 0.500715 | 0.300 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 0.469430 | 0.328 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 0.469430 | 0.328 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 0.469430 | 0.328 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 0.412975 | 0.384 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 0.198954 | 0.701 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 0.234693 | 0.629 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 0.473638 | 0.325 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 0.335844 | 0.474 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 0.371394 | 0.430 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 0.480971 | 0.318 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 0.169018 | 0.772 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 0.169018 | 0.772 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 0.169123 | 0.772 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 0.225546 | 0.647 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 0.225546 | 0.647 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 0.169018 | 0.772 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 0.253299 | 0.596 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 0.234229 | 0.630 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 0.335844 | 0.474 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 0.173983 | 0.759 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 0.330992 | 0.480 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 0.388084 | 0.411 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 0.358290 | 0.446 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 0.318645 | 0.497 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 0.144332 | 0.841 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 0.237452 | 0.624 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 0.129240 | 0.889 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 0.150387 | 0.823 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 0.194389 | 0.711 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 0.194389 | 0.711 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 0.321912 | 0.492 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 0.335844 | 0.474 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 0.460753 | 0.337 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 0.280451 | 0.552 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 0.280451 | 0.552 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 0.311621 | 0.506 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 0.353166 | 0.452 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 0.239735 | 0.620 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 0.189400 | 0.723 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 0.262618 | 0.581 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 0.463365 | 0.334 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 0.404664 | 0.393 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 0.324688 | 0.489 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 0.418982 | 0.378 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 0.259748 | 0.585 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 0.331932 | 0.479 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 0.331243 | 0.480 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 0.262618 | 0.581 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 0.488458 | 0.311 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 0.172154 | 0.764 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 0.353166 | 0.452 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 0.308326 | 0.511 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 0.463365 | 0.334 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 0.418982 | 0.378 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 0.219167 | 0.659 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 0.251964 | 0.599 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 0.388084 | 0.411 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 0.480971 | 0.318 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 0.290506 | 0.537 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 0.174882 | 0.757 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 0.203518 | 0.691 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 0.285510 | 0.544 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 0.489031 | 0.311 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 0.141108 | 0.850 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 0.443120 | 0.353 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 0.489031 | 0.311 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 0.340812 | 0.467 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 0.267411 | 0.573 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 0.173983 | 0.759 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 0.308326 | 0.511 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 0.253919 | 0.595 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 0.353444 | 0.452 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 0.463365 | 0.334 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 0.397484 | 0.401 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 0.243357 | 0.614 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 0.423881 | 0.373 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 0.239735 | 0.620 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 0.173983 | 0.759 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 0.479920 | 0.319 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 0.172154 | 0.764 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 0.330992 | 0.480 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 0.130196 | 0.885 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 0.274559 | 0.561 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 0.220364 | 0.657 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 0.267411 | 0.573 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 0.267411 | 0.573 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 0.172154 | 0.764 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 0.311621 | 0.506 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 0.144332 | 0.841 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 0.353166 | 0.452 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 0.392206 | 0.406 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 0.392206 | 0.406 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 0.428892 | 0.368 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 0.171964 | 0.765 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 0.287274 | 0.542 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 0.495760 | 0.305 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 0.495760 | 0.305 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 0.262003 | 0.582 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 0.418982 | 0.378 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 0.418982 | 0.378 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 0.319154 | 0.496 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 0.440082 | 0.356 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 0.453513 | 0.343 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 0.500715 | 0.300 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 0.456397 | 0.341 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 0.261545 | 0.582 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 0.349800 | 0.456 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 0.133723 | 0.874 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 0.136961 | 0.863 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 0.418982 | 0.378 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 0.184948 | 0.733 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 0.335844 | 0.474 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 0.500715 | 0.300 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 0.358290 | 0.446 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 0.330992 | 0.480 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 0.371955 | 0.430 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 0.375624 | 0.425 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 0.440082 | 0.356 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 0.353444 | 0.452 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 0.353444 | 0.452 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 0.280451 | 0.552 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 0.353166 | 0.452 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 0.375624 | 0.425 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 0.375624 | 0.425 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 0.495760 | 0.305 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 0.298590 | 0.525 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 0.280451 | 0.552 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 0.218581 | 0.660 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 0.470768 | 0.327 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 0.410691 | 0.386 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 0.428424 | 0.368 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 0.404664 | 0.393 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 0.266812 | 0.574 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 0.428424 | 0.368 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 0.311621 | 0.506 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 0.262618 | 0.581 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 0.262618 | 0.581 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 0.262618 | 0.581 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 0.463365 | 0.334 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 0.154620 | 0.811 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 0.236815 | 0.626 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 0.155857 | 0.807 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 0.459324 | 0.338 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 0.299412 | 0.524 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 0.294351 | 0.531 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 0.363761 | 0.439 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 0.262748 | 0.580 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 0.377708 | 0.423 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 0.395779 | 0.403 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 0.437400 | 0.359 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 0.304084 | 0.517 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 0.380161 | 0.420 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 0.480603 | 0.318 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 0.500615 | 0.300 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 0.238315 | 0.623 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 0.211803 | 0.674 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 0.172154 | 0.764 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 0.311621 | 0.506 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 0.311621 | 0.506 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 0.392206 | 0.406 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 0.308326 | 0.511 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 0.270539 | 0.568 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 0.226741 | 0.644 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 0.130558 | 0.884 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 0.463365 | 0.334 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 0.337790 | 0.471 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 0.404664 | 0.393 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 0.437400 | 0.359 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 0.453513 | 0.343 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 0.479920 | 0.319 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 0.429489 | 0.367 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 0.437400 | 0.359 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 0.514931 | 0.288 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 0.499532 | 0.301 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 0.309932 | 0.509 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 0.371394 | 0.430 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 0.159499 | 0.797 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 0.402509 | 0.395 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 0.283266 | 0.548 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 0.141108 | 0.850 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 0.142518 | 0.846 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 0.308326 | 0.511 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 0.480971 | 0.318 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 0.410789 | 0.386 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 0.310099 | 0.508 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 0.192276 | 0.716 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 0.173983 | 0.759 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 0.469430 | 0.328 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 0.349977 | 0.456 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 0.226741 | 0.644 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 0.129240 | 0.889 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 0.267411 | 0.573 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 0.172154 | 0.764 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 0.130196 | 0.885 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 0.392206 | 0.406 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 0.428892 | 0.368 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 0.428892 | 0.368 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 0.463365 | 0.334 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 0.280451 | 0.552 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 0.495760 | 0.305 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 0.495760 | 0.305 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 0.404664 | 0.393 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 0.337790 | 0.471 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 0.161897 | 0.791 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 0.221180 | 0.655 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 0.179828 | 0.745 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 0.162453 | 0.789 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 0.179449 | 0.746 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 0.460753 | 0.337 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 0.195597 | 0.709 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 0.262618 | 0.581 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 0.449411 | 0.347 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 0.440457 | 0.356 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 0.466069 | 0.332 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 0.234229 | 0.630 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 0.500715 | 0.300 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 0.473638 | 0.325 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 0.335844 | 0.474 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 0.402047 | 0.396 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 0.150387 | 0.823 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 0.392206 | 0.406 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 0.221180 | 0.655 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 0.216330 | 0.665 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 0.252596 | 0.598 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 0.405496 | 0.392 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 0.367710 | 0.434 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 0.429489 | 0.367 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 0.260555 | 0.584 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 0.140007 | 0.854 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 0.225546 | 0.647 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 0.405496 | 0.392 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 0.321751 | 0.492 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 0.194389 | 0.711 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 0.152460 | 0.817 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 0.353444 | 0.452 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 0.500615 | 0.300 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 0.367710 | 0.434 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 0.216956 | 0.664 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 0.349800 | 0.456 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 0.460753 | 0.337 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 0.256719 | 0.591 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 0.397484 | 0.401 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 0.433037 | 0.363 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 0.355534 | 0.449 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 0.463365 | 0.334 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 0.280451 | 0.552 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 0.205593 | 0.687 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 0.353444 | 0.452 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 0.446679 | 0.350 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 0.397484 | 0.401 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 0.167912 | 0.775 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 0.304084 | 0.517 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 0.211102 | 0.676 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 0.270539 | 0.568 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 0.172018 | 0.764 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 0.432264 | 0.364 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 0.368035 | 0.434 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 0.515852 | 0.287 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 0.515852 | 0.287 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 0.516087 | 0.287 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 0.517806 | 0.286 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 0.517806 | 0.286 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 0.517806 | 0.286 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 0.519855 | 0.284 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 0.519968 | 0.284 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 0.519968 | 0.284 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 0.519968 | 0.284 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 0.519968 | 0.284 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 0.524690 | 0.280 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 0.525942 | 0.279 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 0.525942 | 0.279 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 0.526201 | 0.279 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 0.526201 | 0.279 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 0.526201 | 0.279 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 0.526201 | 0.279 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 0.526201 | 0.279 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 0.526201 | 0.279 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 0.526201 | 0.279 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 0.526201 | 0.279 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 0.526201 | 0.279 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 0.526201 | 0.279 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 0.526201 | 0.279 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 0.526201 | 0.279 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 0.526201 | 0.279 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 0.526201 | 0.279 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 0.526201 | 0.279 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 0.527415 | 0.278 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 0.530837 | 0.275 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 0.533811 | 0.273 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 0.533811 | 0.273 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 0.538625 | 0.269 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 0.538719 | 0.269 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 0.538719 | 0.269 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 0.538719 | 0.269 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 0.544301 | 0.264 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 0.545023 | 0.264 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 0.545558 | 0.263 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 0.545558 | 0.263 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 0.551133 | 0.259 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 0.554806 | 0.256 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 0.554806 | 0.256 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 0.554806 | 0.256 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 0.554806 | 0.256 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 0.554806 | 0.256 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 0.554806 | 0.256 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 0.554806 | 0.256 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 0.554806 | 0.256 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 0.554806 | 0.256 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 0.554806 | 0.256 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 0.554806 | 0.256 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 0.554806 | 0.256 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 0.554806 | 0.256 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 0.554806 | 0.256 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 0.554806 | 0.256 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 0.556059 | 0.255 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 0.560005 | 0.252 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 0.560005 | 0.252 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 0.560005 | 0.252 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 0.560005 | 0.252 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 0.560005 | 0.252 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 0.563461 | 0.249 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 0.563461 | 0.249 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 0.566985 | 0.246 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 0.574674 | 0.241 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 0.574674 | 0.241 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 0.577117 | 0.239 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 0.581685 | 0.235 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 0.581685 | 0.235 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 0.581685 | 0.235 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 0.581685 | 0.235 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 0.581685 | 0.235 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 0.581685 | 0.235 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 0.581685 | 0.235 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 0.581685 | 0.235 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 0.581685 | 0.235 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 0.581685 | 0.235 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 0.581685 | 0.235 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 0.581685 | 0.235 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 0.581901 | 0.235 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 0.585548 | 0.232 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 0.585548 | 0.232 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 0.588413 | 0.230 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 0.591870 | 0.228 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 0.591870 | 0.228 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 0.591870 | 0.228 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 0.591870 | 0.228 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 0.591870 | 0.228 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 0.598304 | 0.223 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 0.598907 | 0.223 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 0.599293 | 0.222 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 0.599293 | 0.222 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 0.599293 | 0.222 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 0.601634 | 0.221 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 0.605059 | 0.218 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 0.606549 | 0.217 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 0.606943 | 0.217 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 0.606943 | 0.217 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 0.606943 | 0.217 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 0.606943 | 0.217 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 0.606943 | 0.217 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 0.606943 | 0.217 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 0.606943 | 0.217 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 0.606943 | 0.217 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 0.606943 | 0.217 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 0.608541 | 0.216 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 0.608541 | 0.216 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 0.610345 | 0.214 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 0.610345 | 0.214 | 0 | 0 |
| Kinesins | R-HSA-983189 | 0.610837 | 0.214 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 0.611569 | 0.214 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 0.614919 | 0.211 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 0.619434 | 0.208 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 0.619434 | 0.208 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 0.620234 | 0.207 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 0.622174 | 0.206 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 0.622979 | 0.206 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 0.624252 | 0.205 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 0.624689 | 0.204 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 0.624689 | 0.204 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 0.624689 | 0.204 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 0.627902 | 0.202 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 0.630678 | 0.200 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 0.630678 | 0.200 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 0.630678 | 0.200 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 0.630678 | 0.200 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 0.630678 | 0.200 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 0.630678 | 0.200 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 0.630678 | 0.200 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 0.630678 | 0.200 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 0.630678 | 0.200 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 0.630678 | 0.200 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 0.630678 | 0.200 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 0.630678 | 0.200 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 0.630678 | 0.200 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 0.630678 | 0.200 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 0.630678 | 0.200 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 0.630678 | 0.200 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 0.630678 | 0.200 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 0.630678 | 0.200 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 0.633193 | 0.198 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 0.634510 | 0.198 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 0.639325 | 0.194 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 0.640315 | 0.194 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 0.640315 | 0.194 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 0.640315 | 0.194 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 0.640315 | 0.194 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 0.640581 | 0.193 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 0.644212 | 0.191 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 0.644212 | 0.191 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 0.644212 | 0.191 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 0.650488 | 0.187 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 0.652952 | 0.185 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 0.652952 | 0.185 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 0.652980 | 0.185 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 0.652980 | 0.185 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 0.652980 | 0.185 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 0.652980 | 0.185 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 0.652980 | 0.185 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 0.654279 | 0.184 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 0.654909 | 0.184 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 0.655424 | 0.183 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 0.655424 | 0.183 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 0.655424 | 0.183 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 0.655424 | 0.183 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 0.659666 | 0.181 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 0.661228 | 0.180 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 0.662944 | 0.179 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 0.665015 | 0.177 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 0.665387 | 0.177 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 0.665387 | 0.177 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 0.668910 | 0.175 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 0.670022 | 0.174 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 0.670022 | 0.174 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 0.670022 | 0.174 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 0.673938 | 0.171 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 0.673938 | 0.171 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 0.673938 | 0.171 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 0.673938 | 0.171 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 0.673938 | 0.171 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 0.673938 | 0.171 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 0.677121 | 0.169 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 0.684114 | 0.165 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 0.684114 | 0.165 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 0.684114 | 0.165 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 0.684698 | 0.165 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 0.685685 | 0.164 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 0.685685 | 0.164 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 0.688218 | 0.162 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 0.693630 | 0.159 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 0.693630 | 0.159 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 0.693630 | 0.159 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 0.693630 | 0.159 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 0.693630 | 0.159 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 0.693630 | 0.159 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 0.693630 | 0.159 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 0.693630 | 0.159 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 0.693630 | 0.159 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 0.693630 | 0.159 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 0.693732 | 0.159 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 0.694884 | 0.158 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 0.696218 | 0.157 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 0.697709 | 0.156 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 0.697709 | 0.156 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 0.697709 | 0.156 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 0.697709 | 0.156 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 0.697709 | 0.156 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 0.697709 | 0.156 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 0.698407 | 0.156 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 0.698407 | 0.156 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 0.699358 | 0.155 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 0.701168 | 0.154 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 0.703677 | 0.153 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 0.704184 | 0.152 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 0.708899 | 0.149 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 0.710194 | 0.149 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 0.710815 | 0.148 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 0.710815 | 0.148 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 0.710815 | 0.148 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 0.710815 | 0.148 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 0.710815 | 0.148 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 0.712135 | 0.147 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 0.712135 | 0.147 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 0.712135 | 0.147 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 0.712135 | 0.147 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 0.712135 | 0.147 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 0.714474 | 0.146 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 0.720217 | 0.143 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 0.720726 | 0.142 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 0.723443 | 0.141 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 0.723628 | 0.140 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 0.723628 | 0.140 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 0.723628 | 0.140 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 0.723924 | 0.140 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 0.727227 | 0.138 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 0.727227 | 0.138 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 0.727227 | 0.138 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 0.729522 | 0.137 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 0.729522 | 0.137 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 0.729522 | 0.137 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 0.729522 | 0.137 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 0.729522 | 0.137 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 0.729522 | 0.137 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 0.729522 | 0.137 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 0.730958 | 0.136 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 0.735601 | 0.133 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 0.735601 | 0.133 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 0.735601 | 0.133 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 0.735601 | 0.133 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 0.735889 | 0.133 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 0.740893 | 0.130 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 0.745861 | 0.127 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 0.745861 | 0.127 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 0.745861 | 0.127 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 0.745861 | 0.127 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 0.745861 | 0.127 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 0.745861 | 0.127 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 0.745861 | 0.127 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 0.745861 | 0.127 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 0.745861 | 0.127 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 0.745861 | 0.127 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 0.747300 | 0.127 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 0.747300 | 0.127 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 0.747300 | 0.127 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 0.747300 | 0.127 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 0.747300 | 0.127 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 0.747300 | 0.127 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 0.750423 | 0.125 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 0.755947 | 0.122 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 0.759577 | 0.119 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 0.759577 | 0.119 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 0.759577 | 0.119 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 0.761213 | 0.118 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 0.761213 | 0.118 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 0.761213 | 0.118 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 0.761213 | 0.118 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 0.761213 | 0.118 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 0.761213 | 0.118 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 0.761213 | 0.118 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 0.761213 | 0.118 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 0.761213 | 0.118 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 0.765533 | 0.116 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 0.766130 | 0.116 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 0.768950 | 0.114 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 0.769367 | 0.114 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 0.772074 | 0.112 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 0.774715 | 0.111 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 0.775639 | 0.110 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 0.775639 | 0.110 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 0.775639 | 0.110 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 0.775639 | 0.110 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 0.775639 | 0.110 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 0.775639 | 0.110 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 0.775639 | 0.110 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 0.775639 | 0.110 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 0.777734 | 0.109 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 0.777734 | 0.109 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 0.779758 | 0.108 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 0.789195 | 0.103 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 0.789195 | 0.103 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 0.789195 | 0.103 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 0.789195 | 0.103 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 0.789195 | 0.103 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 0.789195 | 0.103 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 0.789737 | 0.103 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 0.789737 | 0.103 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 0.789737 | 0.103 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 0.794477 | 0.100 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 0.794477 | 0.100 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 0.794477 | 0.100 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 0.794477 | 0.100 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 0.794477 | 0.100 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 0.794774 | 0.100 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 0.796314 | 0.099 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 0.796314 | 0.099 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 0.799314 | 0.097 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 0.799314 | 0.097 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 0.799314 | 0.097 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 0.799314 | 0.097 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 0.799314 | 0.097 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 0.799314 | 0.097 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 0.800862 | 0.096 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 0.801932 | 0.096 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 0.801932 | 0.096 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 0.801932 | 0.096 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 0.801932 | 0.096 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 0.801932 | 0.096 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 0.801932 | 0.096 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 0.801932 | 0.096 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 0.801932 | 0.096 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 0.801932 | 0.096 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 0.802446 | 0.096 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 0.808502 | 0.092 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 0.808502 | 0.092 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 0.808502 | 0.092 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 0.808502 | 0.092 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 0.808502 | 0.092 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 0.810154 | 0.091 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 0.810154 | 0.091 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 0.810154 | 0.091 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 0.810154 | 0.091 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 0.812624 | 0.090 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 0.813900 | 0.089 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 0.813900 | 0.089 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 0.813900 | 0.089 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 0.813900 | 0.089 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 0.813900 | 0.089 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 0.813900 | 0.089 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 0.813900 | 0.089 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 0.813900 | 0.089 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 0.816829 | 0.088 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 0.824809 | 0.084 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 0.824809 | 0.084 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 0.825145 | 0.083 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 0.825145 | 0.083 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 0.825145 | 0.083 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 0.825145 | 0.083 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 0.825145 | 0.083 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 0.825145 | 0.083 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 0.825145 | 0.083 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 0.825145 | 0.083 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 0.825761 | 0.083 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 0.828674 | 0.082 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 0.828840 | 0.082 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 0.829539 | 0.081 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 0.830745 | 0.081 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 0.831767 | 0.080 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 0.833855 | 0.079 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 0.833855 | 0.079 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 0.834578 | 0.079 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 0.835712 | 0.078 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 0.835712 | 0.078 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 0.835712 | 0.078 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 0.835712 | 0.078 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 0.835712 | 0.078 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 0.835712 | 0.078 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 0.838727 | 0.076 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 0.841508 | 0.075 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 0.841607 | 0.075 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 0.841607 | 0.075 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 0.841607 | 0.075 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 0.841607 | 0.075 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 0.841607 | 0.075 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 0.841717 | 0.075 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 0.841717 | 0.075 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 0.843867 | 0.074 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 0.845641 | 0.073 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 0.845641 | 0.073 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 0.845641 | 0.073 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 0.845641 | 0.073 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 0.845641 | 0.073 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 0.845641 | 0.073 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 0.847158 | 0.072 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 0.847223 | 0.072 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 0.847223 | 0.072 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 0.849030 | 0.071 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 0.854970 | 0.068 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 0.854970 | 0.068 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 0.854970 | 0.068 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 0.854970 | 0.068 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 0.854970 | 0.068 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 0.854970 | 0.068 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 0.854970 | 0.068 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 0.854970 | 0.068 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 0.854970 | 0.068 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 0.854970 | 0.068 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 0.855073 | 0.068 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 0.856135 | 0.067 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 0.856135 | 0.067 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 0.856135 | 0.067 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 0.857269 | 0.067 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 0.862934 | 0.064 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 0.863091 | 0.064 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 0.863331 | 0.064 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 0.863736 | 0.064 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 0.863736 | 0.064 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 0.863736 | 0.064 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 0.863736 | 0.064 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 0.863736 | 0.064 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 0.866467 | 0.062 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 0.866467 | 0.062 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 0.868703 | 0.061 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 0.871973 | 0.059 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 0.871973 | 0.059 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 0.871973 | 0.059 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 0.871973 | 0.059 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 0.871973 | 0.059 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 0.871973 | 0.059 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 0.871973 | 0.059 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 0.871973 | 0.059 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 0.871973 | 0.059 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 0.871973 | 0.059 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 0.873244 | 0.059 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 0.874111 | 0.058 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 0.875208 | 0.058 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 0.875413 | 0.058 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 0.875654 | 0.058 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 0.875654 | 0.058 | 0 | 0 |
| Protein folding | R-HSA-391251 | 0.877964 | 0.057 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 0.879712 | 0.056 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 0.879712 | 0.056 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 0.879712 | 0.056 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 0.879712 | 0.056 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 0.881598 | 0.055 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 0.886947 | 0.052 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 0.886984 | 0.052 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 0.886984 | 0.052 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 0.886984 | 0.052 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 0.886984 | 0.052 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 0.886984 | 0.052 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 0.886984 | 0.052 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 0.887057 | 0.052 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 0.887279 | 0.052 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 0.887279 | 0.052 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 0.887279 | 0.052 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 0.887279 | 0.052 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 0.889169 | 0.051 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 0.890446 | 0.050 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 0.892705 | 0.049 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 0.893817 | 0.049 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 0.893817 | 0.049 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 0.898291 | 0.047 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 0.899340 | 0.046 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 0.899340 | 0.046 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 0.900237 | 0.046 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 0.900237 | 0.046 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 0.900237 | 0.046 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 0.900890 | 0.045 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 0.902837 | 0.044 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 0.902837 | 0.044 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 0.906269 | 0.043 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 0.906540 | 0.043 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 0.906921 | 0.042 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 0.907561 | 0.042 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 0.907561 | 0.042 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 0.907561 | 0.042 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 0.909479 | 0.041 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 0.911276 | 0.040 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 0.911936 | 0.040 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 0.911936 | 0.040 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 0.913476 | 0.039 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 0.914533 | 0.039 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 0.916398 | 0.038 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 0.917262 | 0.038 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 0.917262 | 0.038 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 0.920475 | 0.036 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 0.920544 | 0.036 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 0.920638 | 0.036 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 0.921983 | 0.035 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 0.922265 | 0.035 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 0.922265 | 0.035 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 0.922265 | 0.035 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 0.922265 | 0.035 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 0.922265 | 0.035 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 0.922265 | 0.035 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 0.922265 | 0.035 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 0.922265 | 0.035 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 0.922265 | 0.035 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 0.922265 | 0.035 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 0.922265 | 0.035 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 0.922265 | 0.035 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 0.924388 | 0.034 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 0.924388 | 0.034 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 0.926967 | 0.033 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 0.926967 | 0.033 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 0.926967 | 0.033 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 0.926967 | 0.033 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 0.926967 | 0.033 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 0.926967 | 0.033 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 0.926967 | 0.033 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 0.928380 | 0.032 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 0.931384 | 0.031 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 0.931384 | 0.031 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 0.931384 | 0.031 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 0.931384 | 0.031 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 0.931504 | 0.031 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 0.931676 | 0.031 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 0.932972 | 0.030 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 0.933369 | 0.030 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 0.935534 | 0.029 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 0.935534 | 0.029 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 0.935534 | 0.029 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 0.935534 | 0.029 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 0.935534 | 0.029 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 0.939434 | 0.027 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 0.939434 | 0.027 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 0.939434 | 0.027 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 0.939434 | 0.027 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 0.939434 | 0.027 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 0.939533 | 0.027 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 0.940028 | 0.027 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 0.943098 | 0.025 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 0.943098 | 0.025 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 0.943098 | 0.025 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 0.943098 | 0.025 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 0.944304 | 0.025 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 0.945322 | 0.024 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 0.945322 | 0.024 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 0.946540 | 0.024 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 0.949343 | 0.023 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 0.949752 | 0.022 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 0.949752 | 0.022 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 0.949775 | 0.022 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 0.949775 | 0.022 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 0.952321 | 0.021 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 0.952321 | 0.021 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 0.952757 | 0.021 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 0.952813 | 0.021 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 0.952813 | 0.021 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 0.952813 | 0.021 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 0.952813 | 0.021 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 0.954462 | 0.020 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 0.954690 | 0.020 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 0.954896 | 0.020 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 0.955669 | 0.020 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 0.955669 | 0.020 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 0.956981 | 0.019 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 0.958351 | 0.018 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 0.958351 | 0.018 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 0.958351 | 0.018 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 0.958951 | 0.018 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 0.960872 | 0.017 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 0.960872 | 0.017 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 0.960872 | 0.017 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 0.960872 | 0.017 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 0.960872 | 0.017 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 0.962126 | 0.017 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 0.963208 | 0.016 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 0.963240 | 0.016 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 0.963240 | 0.016 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 0.963240 | 0.016 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 0.963240 | 0.016 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 0.963240 | 0.016 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 0.964697 | 0.016 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 0.965464 | 0.015 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 0.965464 | 0.015 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 0.965464 | 0.015 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 0.965464 | 0.015 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 0.965529 | 0.015 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 0.968565 | 0.014 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 0.969519 | 0.013 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 0.969519 | 0.013 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 0.970061 | 0.013 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 0.970177 | 0.013 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 0.970177 | 0.013 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 0.970177 | 0.013 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 0.971364 | 0.013 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 0.971364 | 0.013 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 0.971364 | 0.013 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 0.971364 | 0.013 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 0.972122 | 0.012 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 0.974025 | 0.011 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 0.974549 | 0.011 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 0.974726 | 0.011 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 0.974726 | 0.011 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 0.974726 | 0.011 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 0.976256 | 0.010 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 0.976256 | 0.010 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 0.976963 | 0.010 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 0.977113 | 0.010 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 0.977694 | 0.010 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 0.977694 | 0.010 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 0.979045 | 0.009 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 0.979546 | 0.009 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 0.980430 | 0.009 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 0.981506 | 0.008 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 0.982576 | 0.008 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 0.983139 | 0.007 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 0.983139 | 0.007 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 0.983678 | 0.007 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 0.983982 | 0.007 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 0.984260 | 0.007 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 0.984582 | 0.007 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 0.984667 | 0.007 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 0.984667 | 0.007 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 0.984700 | 0.007 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 0.985422 | 0.006 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 0.985428 | 0.006 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 0.985596 | 0.006 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 0.986468 | 0.006 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 0.986610 | 0.006 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 0.987288 | 0.006 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 0.987315 | 0.006 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 0.988058 | 0.005 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 0.988058 | 0.005 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 0.988058 | 0.005 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 0.988058 | 0.005 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 0.988617 | 0.005 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 0.988777 | 0.005 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 0.989227 | 0.005 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 0.989789 | 0.004 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 0.990700 | 0.004 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 0.991264 | 0.004 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 0.991329 | 0.004 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 0.992227 | 0.003 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 0.992227 | 0.003 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 0.992758 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 0.992758 | 0.003 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 0.992758 | 0.003 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 0.993609 | 0.003 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 0.993997 | 0.003 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 0.994361 | 0.002 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 0.994361 | 0.002 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 0.994709 | 0.002 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 0.994993 | 0.002 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 0.995326 | 0.002 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 0.995708 | 0.002 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 0.995708 | 0.002 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 0.995875 | 0.002 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 0.996266 | 0.002 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 0.996408 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 0.997338 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 0.997493 | 0.001 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 0.997652 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 0.997881 | 0.001 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 0.997887 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 0.997928 | 0.001 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 0.998054 | 0.001 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 0.998163 | 0.001 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 0.998283 | 0.001 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 0.998344 | 0.001 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 0.998366 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 0.998485 | 0.001 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 0.998577 | 0.001 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 0.998663 | 0.001 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 0.998663 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 0.998745 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 0.998745 | 0.001 | 0 | 0 |
| Immune System | R-HSA-168256 | 0.998745 | 0.001 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 0.998830 | 0.001 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 0.998955 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 0.999082 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 0.999190 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 0.999334 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 0.999336 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 0.999539 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 0.999577 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 0.999620 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 0.999684 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 0.999721 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 0.999831 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 0.999834 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 0.999876 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 0.999885 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 0.999898 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 0.999904 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 0.999919 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 0.999933 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 0.999941 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 0.999963 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 0.999984 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 0.999985 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 0.999985 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 0.999989 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 0.999993 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 0.999993 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 0.999997 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 0.999997 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 0.999997 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 0.999998 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 0.999998 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 0.999999 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000 | -0.000 | 0 | 0 |